A healthful eating pattern, regular physical activity, and often pharmacotherapy are key components of diabetes management. For many individuals with diabetes, the most challenging part of the treatment plan is determining what to eat. It is the position of the American Diabetes Association (ADA) that there is not a “one-size-fits-all” eating pattern for individuals with diabetes. The ADA also recognizes the integral role of nutrition therapy in overall diabetes management and has historically recommended that each person with diabetes be actively engaged in self-management, education, and treatment planning with his or her health care provider, which includes the collaborative development of an individualized eating plan (1,2). Therefore, it is important that all members of the health care team be knowledgeable about diabetes nutrition therapy and support its implementation.

This position statement on nutrition therapy for individuals living with diabetes replaces previous position statements, the last of which was published in 2008 (3). Unless otherwise noted, research reviewed was limited to those studies conducted in adults diagnosed with type 1 or type 2 diabetes. Nutrition therapy for the prevention of type 2 diabetes and for the management of diabetes complications and gestational diabetes mellitus is not addressed in this review.

A grading system, developed by the ADA and modeled after existing methods, was utilized to clarify and codify the evidence that forms the basis for the recommendations (1) (Table 1). The level of evidence that supports each recommendation is listed after the recommendation using the letters A, B, C, or E. A table linking recommendations to evidence can be reviewed at http://professional.diabetes.org/nutrition. Members of the Nutrition Recommendations Writing Group Committee disclosed all potential financial conflicts of interest with industry. These disclosures were discussed at the onset of the position statement development process. Members of this committee, their employers, and their disclosed conflicts of interest are listed in the acknowledgments. The ADA uses general revenues to fund development of its position statements and does not rely on industry support for these purposes.

Table 1

Nutrition therapy recommendations

• ■ To promote and support healthful eating patterns, emphasizing a variety of nutrient dense foods in appropriate portion sizes, in order to improve overall health and specifically to:

• Attain individualized glycemic, blood pressure, and lipid goals. General recommended goals from the ADA for these markers are as follows:*

• A1C <7%.

• Blood pressure <140/80 mmHg.

• LDL cholesterol <100 mg/dL; triglycerides <150 mg/dL; HDL cholesterol >40 mg/dL for men; HDL cholesterol >50 mg/dL for women.

• Achieve and maintain body weight goals.

• Delay or prevent complications of diabetes.

• ■ To address individual nutrition needs based on personal and cultural preferences, health literacy and numeracy, access to healthful food choices, willingness and ability to make behavioral changes, as well as barriers to change.

• ■ To maintain the pleasure of eating by providing positive messages about food choices while limiting food choices only when indicated by scientific evidence.

• ■ To provide the individual with diabetes with practical tools for day-to-day meal planning rather than focusing on individual macronutrients, micronutrients, or single foods.

*A1C, blood pressure, and cholesterol goals may need to be adjusted for the individual based on age, duration of diabetes, health history, and other present health conditions. Further recommendations for individualization of goals can be found in the ADA Standards of Medical Care in Diabetes (1).

Metabolic control can be considered the cornerstone of diabetes management. Achieving A1C goals decreases the risk for microvascular complications (4,5) and may also be important for cardiovascular disease (CVD) risk reduction, particularly in newly diagnosed patients (68). In addition, achieving blood pressure and lipid goals can help reduce risk for CVD events (9,10). Carbohydrate intake has a direct effect on postprandial glucose levels in people with diabetes and is the primary macronutrient of concern in glycemic management (11). In addition, an individual’s food choices have a direct effect on energy balance and, therefore, on body weight, and food choices can also impact blood pressure and lipid levels. Through the collaborative development of individualized nutrition interventions and ongoing support of behavior changes, health care professionals can facilitate the achievement of their patients’/clients’ health goals (1113).

Ideally, the individual with diabetes should be referred to a registered dietitian (RD) (or a similarly credentialed nutrition professional if outside of the U.S.) for nutrition therapy at—or soon after—diagnosis (11,14) and for ongoing follow-up. Another option for many people is referral to a comprehensive diabetes self-management education (DSME) program that includes instruction on nutrition therapy. Unfortunately, a large percentage of people with diabetes do not receive any structured diabetes education and/or nutrition therapy (15,16). National data indicate that about half of the people with diabetes report receiving some type of diabetes education (17) and even fewer see an RD. In one study of 18,404 patients with diabetes, only 9.1% had at least one nutrition visit within a 9-year period (18). Many people with diabetes, as well as their health care provider(s), are not aware that these services are available to them. Therefore this position statement offers evidence-based nutrition recommendations for all health care professionals to use.

In 1999, the Institute of Medicine (IOM) released a report concluding that evidence demonstrates that medical nutrition therapy (MNT) can improve clinical outcomes while possibly decreasing the cost to Medicare of managing diabetes (19). The IOM recommended that individualized MNT, provided by an RD upon physician referral, be a covered Medicare benefit as part of the multidisciplinary approach to diabetes care (19). MNT is an evidence-based application of the Nutrition Care Process provided by the RD and is the legal definition of nutrition counseling by an RD in the U.S. (20). The IOM also defines nutrition therapy, which has a broader definition than MNT (19). Nutrition therapy is the treatment of a disease or condition through the modification of nutrient or whole-food intake. The definition does not specify that nutrition therapy must be provided by an RD (19). However, both MNT and nutrition therapy should involve a nutrition assessment, nutrition diagnosis, nutrition interventions (e.g., education and counseling), and nutrition monitoring and evaluation with ongoing follow-up to support long-term lifestyle changes, evaluate outcomes, and modify interventions as needed (20).

Nutrition therapy studies included in this position statement use a wide assortment of nutrition professionals as well as registered and advanced practice nurses or physicians. Health care professionals administering nutrition interventions in studies conducted outside the U.S. did not provide MNT as it is legally defined. As a result, the decision was made to use the term “nutrition therapy” rather than “MNT” in this article, in an effort to be more inclusive of the range of health professionals providing nutrition interventions and to recognize the broad definition of nutrition therapy. However, the unique academic preparation, training, skills, and expertise of the RD make him/her the preferred member of the health care team to provide diabetes MNT (Table 2).

Table 2

Academy of Nutrition and Dietetics Evidence-Based Nutrition Practice Guidelines

In addition to diabetes MNT provided by an RD, DSME and diabetes self-management support (DSMS) are critical elements of care for all people with diabetes and are necessary to improve outcomes in a disease that is largely self-managed (2126). The National Standards for Diabetes Self-Management Education and Support recognize the importance of nutrition as one of the core curriculum topics taught in comprehensive programs. The American Association of Diabetes Educators also recognizes the importance of healthful eating as a core self-care behavior (27). For more information, refer to the ADA’s National Standards for Diabetes Self-Management Education and Support (21).

### Effectiveness of Nutrition Therapy

• Nutrition therapy is recommended for all people with type 1 and type 2 diabetes as an effective component of the over all treatment plan. A

• Individuals who have diabetes should receive individualized MNT as needed to achieve treatment goals, preferably provided by an RD familiar with the components of diabetes MNT. A

• For individuals with type 1 diabetes, participation in an intensive flexible insulin therapy education program using the carbohydrate counting meal planning approach can result in improved glycemic control. A

• For individuals using fixed daily insulin doses, consistent carbohydrate intake with respect to time and amount can result in improved glycemic control and reduce the risk for hypoglycemia. B

• A simple diabetes meal planning approach such as portion control or healthful food choices may be better suited to individuals with type 2 diabetes identified with health and numeracy literacy concerns. This may also be an effective meal planning strategy for older adults. C

• People with diabetes should receive DSME according to national standards and DSMS when their diabetes is diagnosed and as needed thereafter. B

• Because diabetes nutrition therapy can result in cost savings B and improved outcomes such as reduction in A1C A, nutrition therapy should be adequately reimbursed by insurance and other payers. E

The common coexistence of hyperlipidemia and hypertension in people with diabetes requires monitoring of metabolic parameters (e.g., glucose, lipids, blood pressure, body weight, renal function) to ensure successful health outcomes (28). Nutrition therapy that includes the development of an eating pattern designed to lower glucose, blood pressure, and alter lipid profiles is important in the management of diabetes as well as lowering the risk of CVD, coronary heart disease, and stroke. Successful approaches should also include regular physical activity and behavioral interventions to help sustain improved lifestyles (11).

Findings from randomized controlled trials (RCTs) and from systematic and Cochrane reviews demonstrate the effectiveness of nutrition therapy for improving glycemic control and various markers of cardiovascular and hypertension risk (13,14,2946). In the general population, MNT provided by an RD to individuals with an abnormal lipid profile has been shown to reduce daily fat (5–8%), saturated fat (2–4%), and energy intake (232–710 kcal/day), and lower triglycerides (11–31%), LDL cholesterol (7–22%), and total cholesterol (7–21%) levels (47).

Effective nutrition therapy interventions may be a component of a comprehensive group diabetes education program or an individualized session (14,2938,4042,44,45). Reported A1C reductions are similar or greater than what would be expected with treatment with currently available pharmacologic treatments for diabetes. The documented decreases in A1C observed in these studies are type 1 diabetes: −0.3 to −1% (13,39,43,48) and type 2 diabetes: −0.5 to −2% (5,14,2938,4042,44,45,49).

Due to the progressive nature of type 2 diabetes, nutrition and physical activity interventions alone (i.e., without pharmacotherapy) are generally not adequately effective in maintaining persistent glycemic control over time for many individuals. However, after pharmacotherapy is initiated, nutrition therapy continues to be an important component of the overall treatment plan (2). For individuals with type 1 diabetes using multiple daily injections or continuous subcutaneous insulin infusion, a primary focus for nutrition therapy should be on how to adjust insulin doses based on planned carbohydrate intake (13,39,43,5053). For individuals using fixed daily insulin doses, carbohydrate intake on a day-to-day basis should be consistent with respect to time and amount (54,55). Intensive insulin management education programs that include nutrition therapy have been shown to reduce A1C (13). Retrospective studies reveal durable A1C reductions with these types of programs (51,56) and significant improvements in quality of life (57) over time. Finally, nutritional approaches for reducing CVD risk, including optimizing serum lipids and blood pressure, can effectively reduce CVD events and mortality (1).

### Energy Balance

• For overweight or obese adults with type 2 diabetes, reducing energy intake while maintaining a healthful eating pattern is recommended to promote weight loss. A

• Modest weight loss may provide clinical benefits (improved glycemia, blood pressure, and/or lipids) in some individuals with diabetes, especially those early in the disease process. To achieve modest weight loss, intensive lifestyle interventions (counseling about nutrition therapy, physical activity, and behavior change) with ongoing support are recommended. A

More than three out of every four adults with diabetes are at least overweight (17), and nearly half of individuals with diabetes are obese (58). Because of the relationship between body weight (i.e., adiposity) and insulin resistance, weight loss has long been a recommended strategy for overweight or obese adults with diabetes (1). Prevention of weight gain is equally important. Long-term reduction of adiposity is difficult for most people to achieve, and even harder for individuals with diabetes to achieve given the impact of some medications used to improve glycemic control (e.g., insulin, insulin secretagogues, and thiazolidinediones) (59,60). A number of factors may be responsible for increasing adiposity in people with diabetes, including a reduction in glycosuria and thus retention of calories otherwise lost as an effect of therapeutic intervention, changes in food intake, or changes in energy expenditure (6164). If adiposity is a concern, medications that are weight neutral or weight reducing (e.g., metformin, incretin-based therapies, sodium glucose co-transporter 2 [SGLT-2] inhibitors) could be considered. Several intensive DSME and nutrition intervention studies show that glycemic control can be achieved while maintaining weight or even reducing weight when appropriate lifestyle counseling is provided (14,31,35,41,42,44,45,50,65,66).

In interventional studies lasting 12 months or longer and targeting individuals with type 2 diabetes to reduce excess body weight (35,6775), modest weight losses were achieved ranging from 1.9 to 8.4 kg. In the Look AHEAD trial, at study end (∼10 years), the mean weight loss from baseline was 6% in the intervention group and 3.5% in the control group (76,77). Studies designed to reduce excess body weight have used a variety of energy-restricted eating patterns with various macronutrient intakes and occasionally included a physical activity component and ongoing follow-up support. Studies achieving the greatest weight losses, 6.2 kg and 8.4 kg, respectively, included the Mediterranean-style eating pattern (72) and a study testing a comprehensive weight loss program that involved diet (including meal replacements) and physical activity (76). In the studies reviewed, improvements in A1C were noted to persist at 12 months in eight intervention groups within five studies (67,69,72,73,76); however, in one of the studies including data at 18 months, the A1C improvement was not maintained (69). The Mediterranean-style eating pattern reported the largest improvement of A1C at 1 year (−1.2%) (72), and the Look AHEAD study intensive lifestyle intervention reported the next largest improvement (−0.64%) (76). One of these studies included only individuals with newly diagnosed diabetes (72), and the other included predominantly individuals with diabetes early in the disease process (<30% were on insulin) (76). Significant improvements in A1C at 1 year were also reported in other studies using energy-restricted eating plans; these studies used meal replacements (67), or low-fat (72)/high-protein (73), or high-carbohydrate eating patterns (73). Not all weight loss interventions reviewed led to improvements in A1C at 1 year (35,68,70,71,74,75), although these studies tended to achieve less weight loss.

Among the studies reviewed, the most consistently reported significant changes of reducing excess body weight on cardiovascular risk factors were an increase in HDL cholesterol (67,72,73,7577), a decrease in triglycerides (72,73,7678), and a decrease in blood pressure (67,70,72,7577). Despite some improvements in cardiovascular risk factors, the Look AHEAD trial failed to demonstrate reduction in CVD events among individuals randomized to an intensive lifestyle intervention for sustained weight loss (77). Of note, however, those randomized to the intervention experienced statistically significant weight loss, requiring less medication for glycemic control and management of CVD risk factors, and experienced several additional health benefits (e.g., reduced sleep apnea, depression, and urinary incontinence and improved health-related quality of life) (7982).

Intensive lifestyle programs (ongoing, with frequent follow-up) are required to achieve significant reductions in excess body weight and improvements in A1C, blood pressure, and lipids (76,83). Weight loss appears to be most beneficial for individuals with diabetes early in the disease process (72,76,83). In the Look AHEAD study, participants with early-stage diabetes (shortest duration, not treated with insulin, good baseline glycemic control) received the most health benefits with a small percentage of individuals achieving partial or complete diabetes remission (84). It is unclear if the benefits result from the reduction in excess weight or the energy restriction or both. Long-term maintenance of weight, following weight reduction, is possible, but research suggests it requires an intensive program with long-term support. Many individuals do regain a portion of their initial weight loss (77,85). Factors contributing to the individual’s inability to retain maximal weight loss include socioeconomic status, an unsupportive environment, and physiological changes (e.g., compensatory changes in circulating hormones that encourage weight regain after weight loss is achieved) (86).

The optimal macronutrient intake to support reduction in excess body weight has not been established. Thus, the current state of the literature does not support one particular nutrition therapy approach to reduce excess weight, but rather a spectrum of eating patterns that result in reduced energy intake. A weight loss of >6 kg (approximately a 7–8.5% loss of initial body weight), regular physical activity, and frequent contact with RDs appear important for consistent beneficial effects of weight loss interventions (85). In the Look AHEAD study, weight loss strategies associated with lower BMI in overweight or obese individuals with type 2 diabetes included weekly self-weighing, regular consumption of breakfast, and reduced intake of fast foods (87). Other successful strategies included increasing physical activity, reducing portion sizes, using meal replacements (as appropriate), and encouraging individuals with diabetes to eat those foods with the greatest consensus for improving health.

Health professionals should collaborate with individuals with diabetes to integrate lifestyle strategies that prevent weight gain or promote modest, realistic weight loss. The emphases of education and counseling should be on the development of behaviors that support long-term weight loss or weight maintenance with less focus on the outcome of weight loss. Bariatric surgery is recognized as an option for individuals with diabetes who meet the criteria for surgery and is not covered in this review. For recommendations on bariatric surgery, see the ADA Standards of Medical Care (1).

### Optimal Mix of Macronutrients

• Evidence suggests that there is not an ideal percentage of calories from carbohydrate, protein, and fat for all people with diabetes B; therefore, macronutrient distribution should be based on individualized assessment of current eating patterns, preferences, and metabolic goals. E

Although numerous studies have attempted to identify the optimal mix of macronutrients for the meal plans of people with diabetes, a systematic review (88) found that there is no ideal mix that applies broadly and that macronutrient proportions should be individualized. On average, it has been observed that people with diabetes eat about 45% of their calories from carbohydrate, ∼36–40% of calories from fat, and the remainder (∼16–18%) from protein (8991). Regardless of the macronutrient mix, total energy intake should be appropriate to weight management goals. Further, individualization of the macronutrient composition will depend on the metabolic status of the individual (e.g., lipid profile, renal function) and/or food preferences. A variety of eating patterns have been shown modestly effective in managing diabetes including Mediterranean-style, Dietary Approaches to Stop Hypertension (DASH) style, plant-based (vegan or vegetarian), lower-fat, and lower-carbohydrate patterns (36,46,72,92,93).

### Eating Patterns

• A variety of eating patterns (combinations of different foods or food groups) are acceptable for the management of diabetes. Personal preferences (e.g., tradition, culture, religion, health beliefs and goals, economics) and metabolic goals should be considered when recommending one eating pattern over another. E

Eating patterns, also called dietary patterns, is a term used to describe combinations of different foods or food groups that characterize relationships between nutrition and health promotion and disease prevention (94). Individuals eat combinations of foods, not single nutrients, and thus it is important to study diet and disease relationships (95). Factors impacting eating patterns include, but are not limited to, food access/availability of healthful foods, tradition, cultural food systems, health beliefs, knowledge of foods that promote health and prevent disease, and economics/resources to buy health-promoting foods (95).

Eating patterns have also evolved over time to include patterns of food intake among specific populations to eating patterns prescribed to improve health. Patterns naturally occurring within populations based on food availability, culture, or tradition and those prescribed to prevent or manage health conditions are important to research. Eating patterns studied among individuals with type 1 or type 2 diabetes were reviewed to evaluate their impact on diabetes nutrition goals. The following eating patterns (Table 3) were reviewed: Mediterranean, vegetarian, low fat, low carbohydrate, and DASH.

Table 3

Reviewed eating patterns

The Mediterranean-style eating pattern, mostly studied in the Mediterranean region, has been observed to improve cardiovascular risk factors (i.e., lipids, blood pressure, triglycerides) (11,72,88,100) in individuals with diabetes and lower combined end points for CVD events and stroke (83) when supplemented with mixed nuts (including walnuts, almonds, and hazelnuts) or olive oil. Individuals following an energy-restricted Mediterranean-style eating pattern also achieve improvements in glycemic control (88). Given that the studies are mostly in the Mediterranean region, further research is needed to determine if the study results can be generalized to other populations and if similar levels of adherence to the eating pattern can be achieved.

Six vegetarian and low-fat vegan studies (36,93,101103,131) in individuals with type 2 diabetes were reviewed. Studies ranged in duration from 12 to 74 weeks, and the diets did not consistently improve glycemic control or CVD risk factors except when energy intake was restricted and weight was lost. Diets often did result in weight loss (36,101103,131). More research on vegan and vegetarian diets is needed to assess diet quality given studies often focus more on what is not consumed than what is consumed.

The low-fat eating pattern is one that has often been encouraged as a strategy to lose weight or to improve cardiovascular health within the U.S. In the Look AHEAD trial (77), an energy-reduced low-fat eating pattern was encouraged for weight loss, and individuals achieved moderate success (76). However, in a systematic review (88) and in four studies (70,71,75,103a) and in a meta-analysis (103b) published since the systematic review, lowering total fat intake did not consistently improve glycemic control or CVD risk factors. Benefit from a low-fat eating pattern appears to be more likely when energy intake is also reduced and weight loss occurs (76,77).

For a review of the studies focused on a low-carbohydrate eating pattern, see the carbohydrates section. Currently there is inadequate evidence in isocaloric comparison recommending a specific amount of carbohydrates for people with diabetes.

In people without diabetes, the DASH eating plan has been shown to help control blood pressure and lower risk for CVD and is frequently recommended as a healthful eating pattern for the general population (104106). Limited evidence exists on the effects of the DASH eating plan on health outcomes specifically in individuals with diabetes; however, one would expect similar results to other studies using the DASH eating plan. In one small study in people with type 2 diabetes, the DASH eating plan, which included a sodium restriction of 2,300 mg/day, improved A1C, blood pressure, and other cardiovascular risk factors (46). The blood pressure benefits are thought to be due to the total eating pattern, including the reduction in sodium and other foods and nutrients that have been shown to influence blood pressure (99,105).

The evidence suggests that several different macronutrient distributions/ eating patterns may lead to improvements in glycemic and/or CVD risk factors (88). There is no “ideal” conclusive eating pattern that is expected to benefit all individuals with diabetes (88). Total energy intake (and thus portion sizes) is an important consideration no matter which eating pattern the individual with diabetes chooses to eat. Because dietary patterns are influenced by food availability, perception of health-fulness of certain foods and by the individual’s preferences, culture, religion, knowledge, health beliefs, and access to food and resources (e.g., budget/income) (95), these factors should be considered when individualizing eating pattern recommendations.

### Carbohydrates

• Evidence is inconclusive for an ideal amount of carbohydrate intake for people with diabetes. Therefore, collaborative goals should be developed with the individual with diabetes. C

• The amount of carbohydrates and available insulin may be the most important factor influencing glycemic response after eating and should be considered when developing the eating plan. A

• Monitoring carbohydrate intake, whether by carbohydrate counting or experience-based estimation, remains a key strategy in achieving glycemic control. B

• For good health, carbohydrate intake from vegetables, fruits, whole grains, legumes, and dairy products should be advised over intake from other carbohydrate sources, especially those that contain added fats, sugars, or sodium. B

Evidence is insufficient to support one specific amount of carbohydrate intake for all people with diabetes. Collaborative goals should be developed with each person with diabetes. Some published studies comparing lower levels of carbohydrate intake (ranging from 21 g daily up to 40% of daily energy intake) to higher carbohydrate intake levels indicated improved markers of glycemic control and insulin sensitivity with lower carbohydrate intakes (92,100,107111). Four RCTs indicated no significant difference in glycemic markers with a lower-carbohydrate diet compared with higher carbohydrate intake levels (71,112114). Many of these studies were small, were of short duration, and/or had low retention rates (92,107, 109,110,112,113).

Some studies comparing lower levels of carbohydrate intake to higher carbohydrate intake levels revealed improvements in serum lipid/lipoprotein measures, including improved triglycerides, VLDL triglyceride, and VLDL cholesterol, total cholesterol, and HDL cholesterol levels (71,92,100,107,109,111,112,115). A few studies found no significant difference in lipids and lipoproteins with a lower-carbohydrate diet compared with higher carbohydrate intake levels. It should be noted that these studies had low retention rates, which may lead to loss of statistical power and biased results (110,113,116). In many of the reviewed studies, weight loss occurred, confounding the interpretation of results from manipulation of macronutrient content.

Despite the inconclusive results of the studies evaluating the effect of differing percentages of carbohydrates in people with diabetes, monitoring carbohydrate amounts is a useful strategy for improving postprandial glucose control. Evidence exists that both the quantity and type of carbohydrate in a food influence blood glucose level, and total amount of carbohydrate eaten is the primary predictor of glycemic response (55,114,117122). In addition, lower A1C occurred in the Diabetes Control and Complications Trial (DCCT) intensive-treatment group and the Dose Adjustment For Normal Eating (DAFNE) trial participants who received nutrition therapy that focused on the adjustment of insulin doses based on variations in carbohydrate intake and physical activity (13,123).

As for the general U.S. population, carbohydrate intake from vegetables, fruits, whole grains, legumes, and milk should be encouraged over other sources of carbohydrates, or sources with added fats, sugars, or sodium, in order to improve overall nutrient intake (105).

### Glycemic Index and Glycemic Load

• Substituting low–glycemic load foods for higher–glycemic load foods may modestly improve glycemic control. C

The ADA recognizes that education about glycemic index and glycemic load occurs during the development of individualized eating plans for people with diabetes. Some organizations specifically recommend use of low—glycemic index diets (124,125). However the literature regarding glycemic index and glycemic load in individuals with diabetes is complex, and it is often difficult to discern the independent effect of fiber compared with that of glycemic index on glycemic control or other outcomes. Further, studies used varying definitions of low and high glycemic index (11,88,126), and glycemic response to a particular food varies among individuals and can also be affected by the overall mixture of foods consumed (11,126).

Some studies did not show improvement with a lower-glycemic index eating pattern; however, several other studies using low-glycemic index eating patterns have demonstrated A1C decreases of −0.2 to −0.5%. However, fiber intake was not consistently controlled, thereby making interpretation of the findings difficult (88,118,119,127). Results on CVD risk measures are mixed with some showing the lowering of total or LDL cholesterol and others showing no significant changes (120).

### Dietary Fiber and Whole Grains

• People with diabetes should consume at least the amount of fiber and whole grains recommended for the general public. C

Intake of dietary fiber is associated with lower all-cause mortality (128,129) in people with diabetes. Two systematic reviews found little evidence that fiber significantly improves glycemic control (11,88). Studies published since these reviews have shown modest lowering of preprandial glucose (130) and A1C (−0.2 to −0.3%) (119,130) with intakes of >50 g of fiber/day. Most studies on fiber in people with diabetes are of short duration, have a small sample size, and evaluate the combination of high-fiber and low-glycemic index foods, and in some cases weight loss, making it difficult to isolate fiber as the sole determinant of glycemic improvement (119,131133). Fiber intakes to improve glycemic control, based on existing research, are also unrealistic, requiring fiber intakes of >50 g/day.

Studies examining fiber’s effect on CVD risk factors are mixed; however, total fiber intake, especially from natural food sources (vs. supplements), seems to have a beneficial effect on serum cholesterol levels and other CVD risk factors such as blood pressure (11,88,134). Because of the general health benefits of fiber, recommendations for the general public to increase intake to 14 g fiber/1,000 kcals daily or about 25 g/day for adult women and 38 g/day for adult men are encouraged for individuals with diabetes (105).

Research has also compared the benefits of whole grains to fiber. The Dietary Guidelines for Americans, 2010 defines whole grains as foods containing the entire grain seed (kernel), bran, germ, and endosperm (105). A systematic review (88) concluded that the consumption of whole grains was not associated with improvements in glycemic control in individuals with type 2 diabetes; however, it may have other benefits, such as reductions in systemic inflammation. Data from the Nurses’ Health Study examining whole grains and their components (cereal fiber, bran, and germ) in relation to all-cause and CVD-specific mortality among women with type 2 diabetes suggest a potential benefit of whole-grain intake in reducing mortality and CVD (128). As with the general population, individuals with diabetes should consume at least half of all grains as whole grains (105).

Resistant starch is defined as starch physically enclosed within intact cell structures as in some legumes, starch granules as in raw potato, and retrograde amylose from plants modified by plant breeding to increase amylose content. It has been proposed that foods containing resistant starch or high amylose foods such as specially formulated cornstarch may modify postprandial glycemic response, prevent hypoglycemia, and reduce hyperglycemia. However, there are no published long-term studies in subjects with diabetes to prove benefit from the use of resistant starch.

Fructans are an indigestible type of fiber that has been hypothesized to have a glucose-lowering effect. Inulin is a fructan commonly added to many processed food products in the form of chicory root. Limited research in people with diabetes is available. One systematic review that included three short-term studies in people with diabetes showed mixed results of fructan intake on glycemia. There are no published long-term studies in subjects with diabetes to prove benefit from the use of fructans (135).

### Substitution of Sucrose for Starch

• While substituting sucrose-containing foods for isocaloric amounts of other carbohydrates may have similar blood glucose effects, consumption should be minimized to avoid displacing nutrient-dense food choices. A

Sucrose is a disaccharide made of glucose and fructose. Commonly known as table sugar or white sugar, it is found naturally in sugar cane and in sugar beets. Research demonstrates that substitution of sucrose for starch for up to 35% of calories may not affect glycemia or lipid levels (11). However, because foods high in sucrose are generally high in calories, substitution should be made in the context of an overall healthful eating pattern with caution not to increase caloric intake. Additionally, as with all people, selection of foods containing sucrose or starch should emphasize more nutrient-dense foods for an overall healthful eating pattern (105).

### Fructose

• Fructose consumed as “free fructose” (i.e., naturally occurring in foods such as fruit) may result in better glycemic control compared with isocaloric intake of sucrose or starch B, and free fructose is not likely to have detrimental effects on triglycerides as long as intake is not excessive (>12% energy). C

• People with diabetes should limit or avoid intake of sugar-sweetened beverages (SSBs) (from any caloric sweetener including high-fructose corn syrup and sucrose) to reduce risk for weight gain and worsening of cardiometabolic risk profile. B

Fructose is a monosaccharide found naturally in fruits. It is also a component of added sugars found in sweetened beverages and processed snacks. The term “free fructose” refers to fructose that is naturally occurring in foods such as fruit and does not include the fructose that is found in the form of the disaccharide sucrose, nor does it include the fructose in high-fructose corn syrup.

Based on two systematic reviews and meta-analyses of studies conducted in persons with diabetes, it appears that free fructose (naturally occurring from foods such as fruit) consumption is not more deleterious than other forms of sugar unless intake exceeds approximately 12% of total caloric intake (136,137). Many foods marketed to people with diabetes may contain large amounts of fructose (such as agave nectar); these foods should not be consumed in large amounts to avoid excess caloric intake and to avoid excessive fructose intake.

In terms of glycemic control, Cozma et al. (138) conducted a systemic review and meta-analysis of controlled feeding trials to study the impact of fructose on glycemic control compared with other sources of carbohydrates. Based on 18 trials, the authors found that isocaloric exchange of fructose for carbohydrates reduced glycated blood proteins and did not significantly affect fasting glucose or insulin. However, it was noted that applicability may be limited because most of the trials were less than 12 weeks in duration. With regard to the treatment of hypoglycemia, in a small study comparing glucose, sucrose, or fructose, Husband et al. (139) found that fructose was the least effective in eliciting the desired upward correction of the blood glucose. Therefore, sucrose or glucose in the form of tablets, liquid, or gel may be the preferred treatment over fruit juice, although availability and convenience should be considered.

There is now abundant evidence from studies of individuals without diabetes that because of their high amounts of rapidly absorbable carbohydrates (such as sucrose or high-fructose corn syrup), large quantities of SSBs should be avoided to reduce the risk for weight gain and worsening of cardiometabolic risk factors (140142). Evidence suggests that consuming high levels of fructose-containing beverages may have particularly adverse effects on selective deposition of ectopic and visceral fat, lipid metabolism, blood pressure, insulin sensitivity, and de novo lipogenesis, compared with glucose-sweetened beverages (142). In terms of specific effects of fructose, concern has been raised regarding elevations in serum triglycerides (143,144). Such studies are not available among individuals with diabetes; however, there is little reason to suspect that the diabetic state would mitigate the adverse effects of SSBs.

### Nonnutritive Sweeteners and Hypocaloric Sweeteners

• Use of nonnutritive sweeteners (NNSs) has the potential to reduce overall calorie and carbohydrate intake if substituted for caloric sweeteners without compensation by intake of additional calories from other food sources. B

The U.S. Food and Drug Administration has reviewed several types of hypo-caloric sweeteners (e.g., NNSs and sugar alcohols) for safety and approved them for consumption by the general public, including people with diabetes (145). Research supports that NNSs do not produce a glycemic effect; however, foods containing NNSs may affect glycemia based on other ingredients in the product (11). An American Heart Association and ADA scientific statement on NNS consumption concludes that there is not enough evidence to determine whether NNS use actually leads to reduction in body weight or reduction in cardiometabolic risk factors (146). These conclusions are consistent with a systematic review of hypocaloric sweeteners (including sugar alcohols) that found little evidence that the use of NNSs lead to reductions in body weight (147). If NNSs are used to replace caloric sweeteners, without caloric compensation, then NNSs may be useful in reducing caloric and carbohydrate intake (146), although further research is needed to confirm these results (147).

### Protein

• For people with diabetes and no evidence of diabetic kidney disease, evidence is inconclusive to recommend an ideal amount of protein intake for optimizing glycemic control or improving one or more CVD risk measures; therefore, goals should be individualized. C

• For people with diabetes and diabetic kidney disease (either micro- or macroalbuminuria), reducing the amount of dietary protein below the usual intake is not recommended because it does not alter glycemic measures, cardiovascular risk measures, or the course of glomerular filtration rate (GFR) decline. A

• In individuals with type 2 diabetes, ingested protein appears to increase insulin response without increasing plasma glucose concentrations. Therefore, carbohydrate sources high in protein should not be used to treat or prevent hypoglycemia. B

Several RCTs have examined the effect of higher protein intake (28–40% of total energy) to usual protein intake (15–19% total) on diabetes outcomes. One study demonstrated decreased A1C with a higher-protein diet (148). However, other studies showed no effect on glycemic control (149151). Some trials comparing higher protein intakes to usual protein intake have shown improved levels of serum triglycerides, total cholesterol, and/or LDL cholesterol (148,150). However, two trials reported no improvement in CVD risk factors (149,151). Factors affecting interpretation of this research include small sample sizes (148,151) and study durations of less than 6 months (148150).

Several RCTs comparing protein levels in individuals with diabetic kidney disease with either micro- or macroalbuminuria had adequately large sample sizes and durations for interpretation. Four studies reported no difference in GFR and/or albumin excretion rate (152155), while one smaller study found some potentially beneficial renal effects with a low-protein diet (156). Two meta-analyses found no clear benefits on renal parameters from low-protein diets (157,158). One factor affecting interpretation of these studies was that actual protein intake differed from goal protein intake. Two studies reported higher actual protein intake in the lower protein group than in the control groups. None of the five reviewed studies since 2000 demonstrated malnourishment as evidenced by hypoalbuminemia with low-protein diets, but both meta-analyses found evidence for this in earlier studies.

There is very limited research in people with diabetes and without kidney disease on the impact of the type of protein consumed. One study did not find a significant difference in glycemic or lipid measures when comparing a chicken- or red meat–based diet (156). For individuals with diabetic kidney disease and macroalbuminuria, changing the source of protein to be more soy-based may improve CVD risk factors but does not appear to alter proteinuria (159,160).

For individuals with type 2 diabetes, protein does not appear to have a significant effect on blood glucose level (161,162) but does appear to increase insulin response (161,163,164). For this reason, it is not advised to use protein to treat hypoglycemia or to prevent hypo-glycemia. Protein’s effect on blood glucose levels in type 1 diabetes is less clear (165,166).

### Total Fat

• Evidence is inconclusive for an ideal amount of total fat intake for people with diabetes; therefore, goals should be individualized. C Fat quality appears to be far more important than quantity. B

Currently, insufficient data exist to determine a defined level of total energy intake from fat at which risk of inadequacy or prevention of chronic disease occurs, so there is no adequate intake or recommended daily allowance for total fat (167). However, the IOM did define an acceptable macronutrient distribution range (AMDR) for total fat of 20–35% of energy with no tolerable upper intake level defined. This AMDR for total fat was “estimated based on evidence indicating a risk for CHD [coronary heart disease] at low intake of fat and high intakes of carbohydrate and on evidence for increased obesity and its complications (CHD) at high intakes of fat” (167). These recommendations are not diabetes-specific; however, limited research exists in individuals with diabetes. Fatty acids are categorized as being saturated or unsaturated (monounsaturated or polyunsaturated). Trans fatty acids may be unsaturated, but they are structurally different and have negative health effects (105). The type of fatty acids consumed is more important than total fat in the diet in terms of supporting metabolic goals and influencing the risk of CVD (83,105,168); thus more attention should be given to the type of fat intake when individualizing goals. Individuals with diabetes should be encouraged to moderate their fat intakes to be consistent with their goals to lose or maintain weight.

### Monounsaturated Fatty Acids/ Polyunsaturated Fatty Acids

• In people with type 2 diabetes, a Mediterranean-style, monounsaturated fatty acid (MUFA)-rich eating pattern may benefit glycemic control and CVD risk factors and can, therefore, be recommended as an effective alternative to a lower-fat, higher-carbohydrate eating pattern. B

Evidence from large prospective cohort studies, clinical trials, and a systematic review of RCTs indicate that high-MUFA diets are associated with improved glycemic control and improved CVD risk or risk factors (70,169171). The intake of MUFA-rich foods as a component of the Mediterranean-style eating pattern has been studied extensively over the last decade. Six published RCTs that included individuals with type 2 diabetes reported improved glycemic control and/or blood lipids when MUFA was substituted for carbohydrate and/or saturated fats (70,72,83,100,108,172). However, some of the studies also included caloric restriction, which may have contributed to improvements in glycemic control or blood lipids (100,108).

In 2011, the Evidence Analysis Library (EAL) of the Academy of Nutrition and Dietetics found strong evidence that dietary MUFAs are associated with improvements in blood lipids based on 13 studies including participants with and without diabetes. According to the EAL, 5% energy replacement of saturated fatty acid (SFA) with MUFA improves insulin responsiveness in insulin-resistant and type 2 diabetic subjects (173).

There is limited evidence in people with diabetes on the effects of omega-6 polyunsaturated fatty acids (PUFAs). Controversy exists on the best ratio of omega-6 to omega-3 fatty acids; PUFAs and MUFAs are recommended substitutes for saturated or trans fat (105,174).

### Omega-3 Fatty Acids

• Evidence does not support recommending omega-3 (EPA and DHA) supplements for people with diabetes for the prevention or treatment of cardiovascular events. A

• As recommended for the general public, an increase in foods containing long-chain omega-3 fatty acids (EPA and DHA) (from fatty fish) and omega-3 linolenic acid (ALA) is recommended for individuals with diabetes because of their beneficial effects on lipoproteins, prevention of heart disease, and associations with positive health outcomes in observational studies. B

• The recommendation for the general public to eat fish (particularly fatty fish) at least two times (two servings) per week is also appropriate for people with diabetes. B

The ADA systematic review identified seven RCTs and one single-arm study (2002–2010) using omega-3 fatty acid supplements and one cohort study on whole-food omega-3 intake. In individuals with type 2 diabetes (88), supplementation with omega-3 fatty acids did not improve glycemic control, but higher-dose supplementation decreased triglycerides. Additional blood-derived markers of CVD risk were not consistently altered in these trials. In subjects with diabetes, six short-duration (30 days to 12 weeks) RCTs were published after the macronutrient review comparing omega-3 (EPA and DHA) supplements to placebo and reported minimal or no beneficial effects (175,176) or mixed/inconsistent beneficial effects (177180) on CVD risk factors and other health issues (e.g., depression). Supplementation with flaxseed (32 g/day) or flaxseed oil (13 g/day) for 12 weeks did not affect glycemic control or adipokines (181). Three longer-duration studies (4 months [182]; 40 months [183]; 6.2 years [184]) also reported mixed outcomes. Two studies reported no beneficial effects of supplementation (183,184). In one study, patients with type 2 diabetes were randomized to atorvastatin or placebo and/or omega-3 supplements (2 g/day) or placebo. No differences on estimated 10-year CVD risks were observed with the addition of omega-3 fatty acid supplements compared with placebo (182). In the largest and longest trial, in patients with type 2 diabetes, supplementation with 1 g/day omega-3 fatty acids compared with placebo did not reduce the rate of cardiovascular events, death from any cause, or death from arrhythmia (184). However, in one study in postmyocardial patients with diabetes, low-dose supplementation of omega-3 fatty acids (400 mg/day) exerted a protective effect on ventricular arrhythmia-related events, and a reduction in mortality was reported (183). Thus, RCTs do not support recommending omega-3 supplements for primary or secondary prevention of CVD despite the strength of evidence from observational and preclinical studies.

Studies in persons with diabetes on the effect of foods containing marine-derived omega-3 fatty acid or the plant-derived omega-3 fatty acid, α-linolenic acid, are limited. Previous studies using supplements had shown mixed effects on fasting blood glucose and A1C levels. However, a study comparing diets with a high proportion of omega-3 (fatty fish) versus omega-6 (lean fish and fat-containing linoleic acid) fatty acids reported both diets had no detrimental effect on glucose measures, and both diets improved insulin sensitivity and lipoprotein profiles (185).

### Saturated Fat, Dietary Cholesterol, and Trans Fat

• The amount of dietary saturated fat, cholesterol, and trans fat recommended for people with diabetes is the same as that recommended for the general population. C

Few research studies have explored the relationship between the amount of SFA in the diet and glycemic control and CVD risk in people with diabetes. A systematic review by Wheeler et al. found just one small 3-week study that compared a low-SFA diet (8% of total kcal) versus a high-SFA diet (17% of total kcal) and found no significant difference in glycemic control and most CVD risk measures (88,186).

In addition, there is limited research regarding optimal dietary cholesterol and trans fat intake in people with diabetes. One large prospective cohort study (171) in women with type 2 diabetes found a 37% increase in CVD risk for every 200 mg cholesterol/1,000 kcal.

Due to the lack of research in this area, people with diabetes should follow the guidelines for the general population. The Dietary Guidelines for Americans, 2010 (105) recommends consuming less than 10% of calories from SFAs to reduce CVD risk. Consumers can meet this guideline by replacing foods high in SFA (i.e., full-fat dairy products, butter, marbled meats and bacon, and tropical oils such as coconut and palm) with items that are rich in MUFA and PUFA (i.e., vegetable and nut oils including canola, corn, safflower, soy, and sunflower; vegetable oil spreads; whole nuts and nut butters, and avocado). CVD is a common cause of death among individuals with diabetes. As a result, individuals with diabetes are encouraged to follow nutrition recommendations similar to the general population to manage CVD risk factors. These recommendations include reducing SFAs to <10% of calories, aiming for <300 mg dietary cholesterol/day, and limiting trans fat as much as possible (105).

### Plant Stanols and Sterols

• Individuals with diabetes and dyslipi-demia may be able to modestly reduce total and LDL cholesterol by consuming 1.6–3 g/day of plant stanols or sterols typically found in enriched foods. C

Plant sterol and stanol esters block the intestinal absorption of dietary and biliary cholesterol (3). Currently, the EAL from the Academy of Nutrition and Dietetics recommends individuals with dyslipidemia incorporate 2–3 g of plant sterol and stanol esters per day as part of a cardioprotective diet through consumption of plant sterol and stanol ester-enriched foods (187). This recommendation, though not specific to people with diabetes, is based on a review of 20 clinical trials (187). Furthermore, the academy reviewed 28 studies that showed no adverse effects with plant stanol/sterol consumption (187).

There is a much smaller body of evidence regarding the cardioprotective effects of phytosterol/stanol consumption specifically in people with diabetes. Beneficial effects on total, LDL cholesterol, and non-HDL cholesterol have been observed in four RCTs (188191). These studies used doses of 1.6–3 g of phytosterols or stanols per day, and interventions lasted 3–12 weeks. Two of these studies were in people with type 1 diabetes (188,189), and one found an added benefit to cholesterol reduction in those who were already on statin treatment (189). In addition, two RCTs compared the efficacy of plant sterol consumption (1.8 g daily) in subjects with type 2 diabetes and subjects without diabetes (191,192). Neither study found a difference in lipid profiles between the two groups, suggesting that efficacy of this treatment is similar for those with and without diabetes who are hypercholesterolemic (191,192).

A wide range of foods and beverages are now available that contain plant sterols including many spreads, dairy products, grain and bread products, and yogurt. These products can contribute a considerable amount of calories. If used, patients should substitute them for comparable foods they eat in order to keep calories balanced and avoid weight gain (3,187).

### Micronutrients and Herbal Supplements

• There is no clear evidence of benefit from vitamin or mineral supplementation in people with diabetes who do not have underlying deficiencies. C

• Routine supplementation with antioxidants, such as vitamins E and C and carotene, is not advised because of lack of evidence of efficacy and concern related to long-term safety. A

• There is insufficient evidence to support the routine use of micro-nutrients such as chromium, magnesium, and vitamin D to improve glycemic control in people with diabetes. C

• There is insufficient evidence to support the use of cinnamon or other herbs/supplements for the treatment of diabetes. C

• It is recommended that individualized meal planning include optimization of food choices to meet recommended dietary allowance/dietary reference intake for all micronutrients. E

There currently exists insufficient evidence of benefit from vitamin or mineral supplementation in people with or without diabetes in the absence of an underlying deficiency (3,193,194). Because uncontrolled diabetes is often associated with micronutrient deficiencies (195), people with diabetes should be aware of the importance of acquiring daily vitamin and mineral requirements from natural food sources and a balanced diet (3). For select groups of individuals such as the elderly, pregnant or lactating women, vegetarians, and those on calorie-restricted diets, a multivitamin supplement may be necessary (196).

While there has been significant interest in antioxidant supplementation as a treatment for diabetes, current evidence not only demonstrates a lack of benefit with respect to glycemic control and progression of complications, but also provides evidence of potential harm of vitamin E, carotene, and other antioxidant supplements (197203).

Findings from supplement studies with micronutrients such as chromium, magnesium, and vitamin D are conflicting and confounded by differences in dosing, micronutrient levels achieved with supplementation, baseline micronutrient status, and/or methodologies used. A systematic review on the effect of chromium supplementation on glucose metabolism and lipids concluded that larger effects were more commonly observed in poor-quality studies and that evidence is limited by poor study quality and heterogeneity in methodology and results (204). Evidence from clinical studies evaluating magnesium (205,206) and vitamin D (207211) supplementation to improve glycemic control in people with diabetes is likewise conflicting.

A systematic review (212) evaluating the effects of cinnamon in people with diabetes concluded there is currently insufficient evidence to support its use, and there is a lack of compelling evidence for the use of other herbal products for the improvement of glycemic control in people with diabetes (213). It is important to consider that herbal products are not standardized and vary in the content of active ingredients and may have the potential to interact with other medications (214). Therefore, it is important that patients/clients with diabetes report the use of supplements and herbal products to their health care providers.

### Alcohol

• If adults with diabetes choose to drink alcohol, they should be advised to do so in moderation (one drink per day or less for adult women and two drinks per day or less for adult men). E

• Alcohol consumption may place people with diabetes at increased risk for delayed hypoglycemia, especially if taking insulin or insulin secretagogues. Education and awareness regarding the recognition and management of delayed hypoglycemia is warranted. C

Moderate alcohol consumption has minimal acute and/or long-term detrimental effects on blood glucose in people with diabetes (215219), with some epidemiologic data showing improved glycemic control with moderate intake. Moderate alcohol intake may also convey cardiovascular risk reduction and mortality benefits in people with diabetes (220223), with the type of alcohol consumed not influencing these beneficial effects (221,224). Accordingly, the recommendations for alcohol consumption for people with diabetes are the same as for the general population. Adults with diabetes choosing to consume alcohol should limit their intake to one serving or less per day for women and two servings or less per day for men (105). Excessive amounts of alcohol (≥3 drinks/day) consumed on a consistent basis may contribute to hyperglycemia (221). One alcohol-containing beverage is defined as 12 oz beer, 5 oz wine, or 1.5 oz distilled spirits, each containing approximately 15 g of alcohol. Abstention from alcohol should be advised, however, for people with a history of alcohol abuse or dependence, women during pregnancy, and people with medical conditions such as liver disease, pancreatitis, advanced neuropathy, or severe hypertriglyceridemia (3).

Despite the potential glycemic and cardiovascular benefits of moderate alcohol consumption, use may place people with diabetes at increased risk for delayed hypoglycemia. This is particularly true in those using insulin or insulin secretagogue therapies. Consuming alcohol with food can minimize the risk of nocturnal hypoglycemia (3,225227). Individuals with diabetes should receive education regarding the recognition and management of delayed hypoglycemia and the potential need for more frequent self-monitoring of blood glucose after consuming alcoholic beverages.

### Sodium

• The recommendation for the general population to reduce sodium to less than 2,300 mg/day is also appropriate for people with diabetes. B

• For individuals with both diabetes and hypertension, further reduction in sodium intake should be individualized. B

Limited studies have been published on sodium reduction in people with diabetes. A Cochrane review of RCTs found that decreasing sodium intake reduces blood pressure in those with diabetes (228). Likewise, a small study in people with type 2 diabetes showed that following the DASH diet and reducing sodium intake to about 2,300 mg led to improvements in blood pressure and other measures on cardiovascular risk factors (46).

Incrementally lower sodium intakes (i.e., to 1,500 mg/day) show more beneficial effects on blood pressure (104,229); however, some studies in people with type 1 (230) and type 2 (231) diabetes measuring urine sodium excretion have shown increased mortality associated with the lowest sodium intakes, therefore warranting caution for universal sodium restriction to 1,500 mg in this population. Additionally, an IOM report suggests there is no evidence on health outcomes to treat certain population subgroups—which includes individuals with diabetes—differently than the general U.S. population (232).

In the absence of clear scientific evidence for benefit in people with combined diabetes and hypertension (230,231), sodium intake goals that are significantly lower than 2,300 mg/day should be considered only on an individual basis. When individualizing sodium intake recommendations, consideration must also be given to issues such as the palatability, availability, and additional cost of specialty low sodium products and the difficulty in achieving both low sodium recommendations and a nutritionally adequate diet given these limitations (233).

While specific dietary sodium targets are highly debated by various health groups, all agree that the current average intake of sodium of 3,400 mg/day (excluding table salt) is excessive and should be reduced (105,234237). The food industry can play a major role in lowering sodium content of foods to help people meet sodium recommendations (233,234).

A wide range of diabetes meal planning approaches or eating patterns have been shown to be clinically effective, with many including a reduced energy intake component. There is not one ideal percentage of calories from carbohydrates, protein, or fat that is optimal for all people with diabetes. Nutrition therapy goals should be developed collaboratively with the individual with diabetes and be based on an assessment of the individual’s current eating patterns, preferences, and metabolic goals. Once a thorough assessment is completed, the health care professional’s role is to facilitate behavior change and achievement of metabolic goals while meeting the patient’s preferences, which may include allowing the patient to continue following his/her current eating pattern. If the individual would like to try a different eating pattern, this should also be supported by the health care team. Various behavior change theories and strategies can be used to tailor nutrition interventions to help the client achieve specific health and quality-of-life outcomes (238).

Multiple meal planning approaches and eating patterns can be effective for achieving metabolic goals. Examples include carbohydrate counting, healthful food choices/simplified meal plans (i.e., the Plate Method), individualized meal planning methods based on percentages of macronutrients, exchange list for meal planning, glycemic index, and eating patterns including Mediterranean style, DASH, vegetarian or vegan, low carbohydrate, and low fat. The meal planning approach or eating pattern should be selected based on the individual’s personal and cultural preferences; literacy and numeracy; and readiness, willingness, and ability to change. This may need to be adjusted over time based on changes in life circumstances, preferences, and disease course.

A summary of key topics for nutrition education can be found in Table 4.

Table 4

Summary of priority topics

The evidence presented in this position statement concurs with the review previously published by Wheeler et al. (88) that many different approaches to nutrition therapy and eating patterns are effective for the target outcomes of improved glycemic control and reduced CVD risk among individuals with diabetes. Evaluating nutrition evidence is complex given that multiple dietary factors influence glycemic control and CVD risk factors, and the influence of a combination of factors can be substantial. Based on a review of the evidence, it is clear that gaps in the literature continue to exist and further research on nutrition and eating patterns is needed in individuals with type 1 and type 2 diabetes.

For example, future studies should address:

• The relationships between eating patterns and disease in diverse populations.

• The basis for the beneficial effects of the Mediterranean-style eating pattern and approaches to translation of the Mediterranean-style eating pattern into diverse populations.

• The development of standardized definitions for high– and low–glycemic index diets and implementation of these definitions in long-term studies to further evaluate their impact on glycemic control.

• The development of standardized definitions for low- to moderate-carbohydrate diets and determining long-term sustainability.

• Whether NNSs, when used to replace caloric sweeteners, are useful in reducing caloric and carbohydrate intake.

• The impact of key nutrients on cardiovascular risk, such as saturated fat, cholesterol, and sodium in individuals with both type 1 and type 2 diabetes.

• Intake of SFA and its relationship to insulin resistance.

Importantly, research needs to move away from just evaluating the impact of individual nutrients on glycemic control and cardiovascular risk. More research on eating patterns, unrestricted and restricted energy diets, and diverse populations is needed to evaluate their long-term health benefits in individuals with diabetes. Individuals eat nutrients from foods and within the context of mixed meals, and nutrient intakes are intercorrelated, so overall eating patterns must be studied to fully understand how these eating patterns impact glycemic control (88, 240). Eating patterns are selected by individuals based on more than the healthfulness of food and food availability; tradition, cultural food systems, health beliefs, and economics are also important (95). Studies on gene-diet interactions will also be important, as well as studies on potential epigenetic effects that depend on nutrients to moderate gene expression.

Given the benefits of both nutrition therapy and MNT for individuals with diabetes, it is also important to study systematic processes within the context of health care delivery that encourage more individuals with diabetes to receive nutrition therapy initially, upon diagnosis, and long term. Further research is also needed on the best tools and strategies for educating individuals with diabetes (e.g., the Plate Method) and how to improve adherence to healthful eating patterns among individuals with diabetes. This research should include multiple settings that can impact food choices for individuals with diabetes, such as where they live, work, learn, and play. Individuals with diabetes spend the majority of their time outside health care settings so more research on how public health, the health care system, and the community can support individuals with diabetes in their efforts to achieve healthful eating is needed.

There is no standard meal plan or eating pattern that works universally for all people with diabetes (1). In order to be effective, nutrition therapy should be individualized for each patient/client based on his or her individual health goals; personal and cultural preferences (241,242); health literacy and numeracy (243,244); access to healthful choices (245,246); and readiness, willingness, and ability to change. Nutrition interventions should emphasize a variety of minimally processed nutrient-dense foods in appropriate portion sizes as part of a healthful eating pattern and provide the individual with diabetes with practical tools for day-to-day food plan and behavior change that can be maintained over the long term.

Acknowledgments. This position statement was written at the request of the ADA Executive Committee, which has approved the final document. The process involved extensive literature review, one face-to-face meeting of the entire writing group, one subgroup writing meeting, numerous teleconferences, and multiple revisions via e-mail communications.

The final draft was also reviewed and approved by the Professional Practice Committee of the ADA. The authors are indebted to Sue Kirkman, MD, for her guidance and support during this process.

The two face-to-face meetings and the travel of the writing group and teleconference calls were supported by the ADA.

The authors also gratefully acknowledge the following experts who provided critical review of a draft of this statement: Jane Chiang, MD, American Diabetes Association, Alexandria, VA; Joan Hill, RD, CDE, Hill Nutrition Consulting LLC, Boston, MA; Sue Kirkman, MD, University of North Carolina, Chapel Hill, NC; Penny Kris-Etherton, PhD, RD, Penn State, University Park, PA; Melinda Maryniuk, MS, RD, FADA, CDE, Joslin Diabetes Center, Boston, MA; Dariush Mozaffarian, MD, Harvard School of Public Health, Boston, MA; and Madelyn Wheeler, MS, RD, FADA, Nutritional Computing Concepts, Zionsville, IN.

Duality of Interest. During the past 12 months, the following relationships with companies whose products or services directly relate to the subject matter in this document are declared: A.B.E.: no conflicts of interest to report. J.L.B.: research with CDC >$10,000, money goes to institution. M.C.: consultant/advisory board with Becton Dickenson. S.A.D.: no conflicts of interest to report. M.J.F.: no conflicts of interest to report. E.J.M.-D.: research with Abbott Diabetes Care and Eli Lilly >$10,000, money goes to institution. J.J.N.: research with AstraZeneca, Bristol-Myers Squibb, Johnson & Johnson, Novo Nordisk, Merck, and Eli Lilly >$10,000, money goes to institution; consultant/advisory board with Janssen Phamaceuticals; other research support through the National Institutes of Health (NIH) and the Patient-Centered Outcomes Research Institute. R.N.: consultant/ advisory board with Boehringer Ingelheim, Eli Lilly, Type Free Inc., NIH/National Institute of Diabetes and Digestive and Kidney Diseases Advisory Council. C.L.V.: no conflicts of interest to report. P.U.: speakers’ bureau/honoraria with Eli Lilly and consultant/advisory board with Eli Lilly, Sanofi, Halozyme Therapeutics, Medtronic, YourEncore, Janssen Pharmaceuticals. W.S.Y.: research with NIH and the Veterans Administration >$10,000, money goes to institution; spouse employee of ViiV Healthcare >\$10,000. No other potential conflicts of interest relevant to this article were reported.

Author Contributions. All the named writing group authors contributed substantially to the document including researching data, contributing to discussions, writing and reviewing text, and editing the manuscript. All authors supplied detailed input and approved the final version. A.B.E. and J.L.B. directed, chaired, and coordinated the input with multiple e-mail exchanges or telephone calls between all participants.

1.
American Diabetes Association
.
Standards of medical care in diabetes—2014
.
Diabetes Care
2014
;
37
(
Suppl. 1
):
S14
S80
2.
Inzucchi
SE
,
Bergenstal
RM
,
Buse
JB
, et al
American Diabetes Association (ADA)
;
European Association for the Study of Diabetes (EASD). Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
.
Diabetes Care
2012
;
35
:
1364
1379
3.
Bantle
JP
,
Wylie-Rosett
J
,
Albright
AL
, et al
American Diabetes Association
.
Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association
.
Diabetes Care
2008
;
31
(
Suppl. 1
):
S61
S78
4.
The Diabetes Control and Complications Trial Research Group
.
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
.
N Engl J Med
1993
;
329
:
977
986
5.
UK Prospective Diabetes Study (UKPDS) Group
.
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
.
Lancet
1998
;
352
:
854
865
6.
Nathan
DM
,
Zinman
B
,
Cleary
PA
, et al
.;
Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group. Modern-day clinical course of type 1 diabetes mellitus after 30 years’ duration: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications and Pittsburgh Epidemiology of Diabetes Complications Experience (1983–2005)
.
Arch Intern Med
2009
;
169
:
1307
1316
7.
Holman
RR
,
Paul
SK
,
Bethel
MA
,
Matthews
DR
,
Neil
HA
.
10-year follow-up of intensive glucose control in type 2 diabetes
.
N Engl J Med
2008
;
359
:
1577
1589
8.
Turnbull
FM
,
Abraira
C
,
Anderson
RJ
, et al
Control Group
.
Intensive glucose control and macrovascular outcomes in type 2 diabetes
.
Diabetologia
2009
;
52
:
2288
2298
9.
Chobanian
AV
,
Bakris
GL
,
Black
HR
, et al
.;
National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report
.
JAMA
2003
;
289
:
2560
2572
10.
Kearney
PM
,
Blackwell
L
,
Collins
R
, et al
.;
Cholesterol Treatment Trialists’ (CTT) Collaborators. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis
.
Lancet
2008
;
371
:
117
125
11.
Franz
MJ
,
Powers
MA
,
Leontos
C
, et al
.
The evidence for medical nutrition therapy for type 1 and type 2 diabetes in adults
.
J Am Diet Assoc
2010
;
110
:
1852
1889
12.
Al-Sinani
M
,
Min
Y
,
Ghebremeskel
K
,
Qazaq
HS
.
Effectiveness of and adherence to dietary and lifestyle counselling: effect on metabolic control in type 2 diabetic Omani patients
.
Sultan Qaboos Univ Med J
2010
;
10
:
341
349
13.
DAFNE Study Group
.
Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: Dose Adjustment For Normal Eating (DAFNE) randomised controlled trial
.
BMJ
2002
;
325
:
746
14.
Andrews
RC
,
Cooper
AR
,
Montgomery
AA
, et al
.
Diet or diet plus physical activity versus usual care in patients with newly diagnosed type 2 diabetes: the Early ACTID randomised controlled trial
.
Lancet
2011
;
378
:
129
139
15.
Siminerio
LM
,
Piatt
G
,
Zgibor
JC
.
Implementing the chronic care model for improvements in diabetes care and education in a rural primary care practice
.
Diabetes Educ
2005
;
31
:
225
234
16.
Siminerio
LM
,
Piatt
GA
,
Emerson
S
, et al
.
Deploying the chronic care model to implement and sustain diabetes self-management training programs
.
Diabetes Educ
2006
;
32
:
253
260
17.
Ali
MK
,
Bullard
KM
,
JB
,
Cowie
CC
,
Imperatore
G
,
Gregg
EW
.
Achievement of goals in U.S. diabetes care, 1999–2010
.
N Engl J Med
2013
;
368
:
1613
1624
18.
Robbins
JM
,
Thatcher
GE
,
Webb
DA
,
Valdmanis
VG
.
Nutritionist visits, diabetes classes, and hospitalization rates and charges: the Urban Diabetes Study
.
Diabetes Care
2008
;
31
:
655
660
19.
Institute of Medicine
.
The Role of Nutrition in Maintaining Health in the Nation’s Elderly: Evaluating Coverage of Nutrition Services for the Medicare Population
.
Washington, DC
,
,
2000
20.
Lacey
K
,
Pritchett
E
.
Nutrition care process and model: ADA adopts road map to quality care and outcomes management
.
J Am Diet Assoc
2003
;
103
:
1061
1072
21.
Haas
L
,
Maryniuk
M
,
Beck
J
, et al
.;
2012 Standards Revision Task Force. National standards for diabetes self-management education and support
.
Diabetes Care
2014
;
37(Suppl. 1)
:
S144
S153
22.
Gary
TL
,
Genkinger
JM
,
Guallar
E
,
Peyrot
M
,
Brancati
FL
.
Meta-analysis of randomized educational and behavioral interventions in type 2 diabetes
.
Diabetes Educ
2003
;
29
:
488
501
23.
Norris
SL
,
Lau
J
,
Smith
SJ
,
Schmid
CH
,
Engelgau
MM
.
Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control
.
Diabetes Care
2002
;
25
:
1159
1171
24.
Renders
CM
,
Valk
GD
,
Griffin
SJ
,
Wagner
EH
,
Eijk Van
JT
,
Assendelft
WJ
.
Interventions to improve the management of diabetes in primary care, outpatient, and community settings: a systematic review
.
Diabetes Care
2001
;
24
:
1821
1833
25.
Brown
SA
,
Hanis
CL
.
Culturally competent diabetes education for Mexican Americans: the Starr County Study
.
Diabetes Educ
1999
;
25
:
226
236
26.
Deakin
T
,
McShane
CE
,
JE
,
Williams
RD
.
Group based training for self-management strategies in people with type 2 diabetes mellitus
.
Cochrane Database Syst Rev
2005
;
2
:CD003417
27.
American Association of Diabetes Educators
.
Guidelines for the Practice of Diabetes Self-Management Education and Training (DSME/T). Chicago, American Association of Diabetes Educators
,
2010
28.
Karmally
W
.
Nutrition Therapy for Diabetes and Lipid Disorders
. In
American Diabetes Association Guide to Nutrition Therapy for Diabetes.
Franz
M
,
Evert
A
, Eds. Alexandria, VA, American Diabetes Association,
2012
, p.
265
294
29.
Rickheim
PL
,
Weaver
TW
,
JL
,
Kendall
DM
.
Assessment of group versus individual diabetes education: a randomized study
.
Diabetes Care
2002
;
25
:
269
274
30.
Miller
CK
,
Edwards
L
,
Kissling
G
,
Sanville
L
.
Nutrition education improves metabolic outcomes among older adults with diabetes mellitus: results from a randomized controlled trial
.
Prev Med
2002
;
34
:
252
259
31.
Ash
S
,
Reeves
MM
,
Yeo
S
,
Morrison
G
,
Carey
D
,
Capra
S
.
Effect of intensive dietetic interventions on weight and glycaemic control in overweight men with type II diabetes: a randomised trial
.
Int J Obes Relat Metab Disord
2003
;
27
:
797
802
32.
Goldhaber-Fiebert
JD
,
Goldhaber-Fiebert
SN
,
Tristan
ML
,
Nathan
DM
.
Randomized controlled community-based nutrition and exercise intervention improves glycemia and cardiovascular risk factors in type 2 diabetic patients in rural Costa Rica
.
Diabetes Care
2003
;
26
:
24
29
33.
Ziemer
DC
,
Berkowitz
KJ
,
Panayioto
RM
, et al
.
A simple meal plan emphasizing healthy food choices is as effective as an exchange-based meal plan for urban African Americans with type 2 diabetes
.
Diabetes Care
2003
;
26
:
1719
1724
34.
Takahashi
M
,
Araki
A
,
Ito
H
.
Development of a new method for simple dietary education in elderly patients with diabetes mellitus
.
Geriatr Gerontol Int
2004
;
4
:
111
119
35.
Wolf
AM
,
Conaway
MR
,
Crowther
JQ
, et al
.;
Improving Control with Activity and Nutrition (ICAN) Study. Translating lifestyle intervention to practice in obese patients with type 2 diabetes: Improving Control with Activity and Nutrition(ICAN) study
.
Diabetes Care
2004
;
27
:
1570
1576
36.
Barnard
ND
,
Cohen
J
,
Jenkins
DJ
, et al
.
A low-fat vegan diet improves glycemic control and cardiovascular risk factors in a randomized clinical trial in individuals with type 2 diabetes
.
Diabetes Care
2006
;
29
:
1777
1783
37.
Nield
L
,
Moore
HJ
,
Hooper
L
, et al
.
Dietary advice for treatment of type 2 diabetes mellitus in adults
.
Cochrane Database Syst Rev
2007
;
3
:CD004097
38.
Davis
RM
,
Hitch
,
Salaam
MM
,
Herman
WH
,
Zimmer-Galler
IE
,
Mayer-Davis
EJ
.
TeleHealth improves diabetes self-management in an underserved community: diabetes TeleCare
.
Diabetes Care
2010
;
33
:
1712
1717
39.
Rossi
MC
,
Nicolucci
A
,
Di Bartolo
P
, et al
.
Diabetes Interactive Diary: a new telemedicine system enabling flexible diet and insulin therapy while improving quality of life: an open-label, international, multicenter, randomized study
.
Diabetes Care
2010
;
33
:
109
115
40.
Huang
MC
,
Hsu
CC
,
Wang
HS
,
Shin
SJ
.
Prospective randomized controlled trial to evaluate effectiveness of registered dietitian-led diabetes management on glycemic and diet control in a primary care setting in Taiwan
.
Diabetes Care
2010
;
33
:
233
239
41.
Al-Shookri
A
,
Khor
GL
,
Chan
YM
,
Loke
SC
,
M
.
Effectiveness of medical nutrition treatment delivered by dietitians on glycaemic outcomes and lipid profiles of Arab, Omani patients with type 2 diabetes
.
Diabet Med
2012
;
29
:
236
244
42.
Coppell
KJ
,
Kataoka
M
,
Williams
SM
,
Chisholm
AW
,
Vorgers
SM
,
Mann
JI
.
Nutritional intervention in patients with type 2 diabetes who are hyperglycaemic despite optimised drug treatment—Lifestyle Over and Above Drugs in Diabetes (LOADD) study: randomised controlled trial
.
BMJ
2010
;
341
:c3337
43.
Laurenzi
A
,
Bolla
AM
,
Panigoni
G
, et al
.
Effects of carbohydrate counting on glucose control and quality of life over 24 weeks in adult patients with type 1 diabetes on continuous subcutaneous insulin infusion: a randomized, prospective clinical trial (GIOCAR)
.
Diabetes Care
2011
;
34
:
823
827
44.
Tan
MY
,
Magarey
JM
,
Chee
SS
,
Lee
LF
,
Tan
MH
.
A brief structured education programme enhances self-care practices and improves glycaemic control in Malaysians with poorly controlled diabetes
.
Health Educ Res
2011
;
26
:
896
907
45.
Battista
MC
,
Labonté
M
,
Ménard
J
, et al
.
Dietitian-coached management in combination with annual endocrinologist follow up improves global metabolic and cardiovascular health in diabetic participants after 24 months
.
Appl Physiol Nutr Metab
2012
;
37
:
610
620
46.
L
,
Fard
NR
,
Karimi
M
, et al
.
Effects of the Dietary Approaches to Stop Hypertension (DASH) eating plan on cardiovascular risks among type 2 diabetic patients: a randomized crossover clinical trial
.
Diabetes Care
2011
;
34
:
55
57
47.
Academy of Nutrition and Dietetics
.
Disorders of lipid metabolism [Internet], 2010. Evidence Analysis Library
. Available from http://andevidencelibrary.com/topic.cfm?cat=3582&auth=1. Accessed 1 July
2013
48.
Kulkarni
K
,
Castle
G
,
Gregory
R
, et al
.;
The Diabetes Care and Education Dietetic Practice Group. Nutrition Practice Guidelines for type 1 diabetes mellitus positively affect dietitian practices and patient outcomes
.
J Am Diet Assoc
1998
;
98
:
62
70
49.
Franz
MJ
,
Monk
A
,
Barry
B
, et al
.
Effectiveness of medical nutrition therapy provided by dietitians in the management of non-insulin-dependent diabetes mellitus: a randomized, controlled clinical trial
.
J Am Diet Assoc
1995
;
95
:
1009
1017
50.
Graber
AL
,
Elasy
TA
,
Quinn
D
,
Wolff
K
,
Brown
A
.
Improving glycemic control in adults with diabetes mellitus: shared responsibility in primary care practices
.
South Med J
2002
;
95
:
684
690
51.
Sämann
A
,
Muhlhauser
I
,
Bender
R
,
Ch
Kloos
,
Muller
UA
.
Glycaemic control and severe hypoglycaemia following training in flexible, intensive insulin therapy to enable dietary freedom in people with type 1 diabetes: a prospective implementation study
.
Diabetologia
2005
;
48
:
1965
1970
52.
Lowe
J
,
Linjawi
S
,
Mensch
M
,
James
K
,
Attia
J
.
Flexible eating and flexible insulin dosing in patients with diabetes: results of an intensive self-management course
.
Diabetes Res Clin Pract
2008
;
80
:
439
443
53.
Scavone
G
,
Manto
A
,
Pitocco
D
, et al
.
Effect of carbohydrate counting and medical nutritional therapy on glycaemic control in type 1 diabetic subjects: a pilot study
.
Diabet Med
2010
;
27
:
477
479
54.
Wolever
TM
,
S
,
Chiasson
JL
, et al
.
Day-to-day consistency in amount and source of carbohydrate intake associated with improved blood glucose control in type 1 diabetes
.
J Am Coll Nutr
1999
;
18
:
242
247
55.
Rabasa-Lhoret
R
,
Garon
J
,
Langelier
H
,
Poisson
D
,
Chiasson
JL
.
Effects of meal carbohydrate content on insulin requirements in type 1 diabetic patients treated intensively with the basal-bolus(ultralente-regular) insulin regimen
.
Diabetes Care
1999
;
22
:
667
673
56.
McIntyre
HD
,
Knight
BA
,
Harvey
DM
,
Noud
MN
,
Hagger
VL
,
Gilshenan
KS
.
Dose Adjustment For Normal Eating (DAFNE) - an audit of outcomes in Australia
.
Med J Aust
2010
;
192
:
637
640
57.
Speight
J
,
Amiel
SA
,
C
, et al
.
Long-term biomedical and psychosocial outcomes following DAFNE (Dose Adjustment For Normal Eating) structured education to promote intensive insulin therapy in adults with sub-optimally controlled type 1 diabetes
.
Diabetes Res Clin Pract
2010
;
89
:
22
29
58.
Nguyen
NT
,
Nguyen
XM
,
Lane
J
,
Wang
P
.
Relationship between obesity and diabetes in a US adult population: findings from the National Health and Nutrition Examination Survey
,
1999–2006.Obes Surg
2011
;
21
:
351
355
59.
UK Prospective Diabetes Study 7
UK Prospective Diabetes Study 7: response of fasting plasma glucose to diet therapy in newly presenting type II diabetic patients, UKPDS Group.
Metabolism
1990
;
39
:
905
912
60.
Fonseca
V
,
McDuffie
R
,
Calles
J
, et al
ACCORD Study Group
.
Determinants of weight gain in the action to control cardiovascular risk in diabetes trial
.
Diabetes Care
2013
;
36
:
2162
2168
61.
Carlson
MG
,
Campbell
PJ
.
Intensive insulin therapy and weight gain in IDDM
.
Diabetes
1993
;
42
:
1700
1707
62.
Heller
S
.
Weight gain during insulin therapy in patients with type 2 diabetes mellitus
.
Diabetes Res Clin Pract
2004
;
65
(
Suppl. 1
):
S23
S27
63.
Jacob
AN
,
Salinas
K
,
B
,
P
.
Weight gain in type 2 diabetes mellitus
.
Diabetes Obes Metab
2007
;
9
:
386
393
64.
McMinn
JE
,
DG
,
Schwartz
MW
.
Neuroendocrine mechanisms regulating food intake and body weight
.
Obes Rev
2000
;
1
:
37
46
65.
Banister
NA
,
Jastrow
ST
,
Hodges
V
,
Loop
R
,
Gillham
MB
.
Diabetes self-management training program in a community clinic improves patient outcomes at modest cost
.
J Am Diet Assoc
2004
;
104
:
807
810
66.
Barratt
R
,
Frost
G
,
Millward
DJ
,
Truby
H
.
A randomised controlled trial investigating the effect of an intensive lifestyle intervention v. standard care in adults with type 2 diabetes immediately after initiating insulin therapy
.
Br J Nutr
2008
;
99
:
1025
1031
67.
Metz
JA
,
Stern
JS
,
Kris-Etherton
P
, et al
.
A randomized trial of improved weight loss with a prepared meal plan in overweight and obese patients: impact on cardiovascular risk reduction
.
Arch Intern Med
2000
;
160
:
2150
2158
68.
Li
Z
,
Hong
K
,
Saltsman
P
, et al
.
Long-term efficacy of soy-based meal replacements vs an individualized diet plan in obese type II DM patients: relative effects on weight loss, metabolic parameters, and C-reactive protein
.
Eur J Clin Nutr
2005
;
59
:
411
418
69.
West
DS
,
DiLillo
V
,
Bursac
Z
,
Gore
SA
,
Greene
PG
.
Motivational interviewing improves weight loss in women with type 2 diabetes
.
Diabetes Care
2007
;
30
:
1081
1087
70.
Brehm
BJ
,
Lattin
BL
,
Summer
SS
, et al
.
One-year comparison of a high-monounsaturated fat diet with a high-carbohydrate diet in type 2 diabetes
.
Diabetes Care
2009
;
32
:
215
220
71.
Davis
NJ
,
Tomuta
N
,
Schechter
C
, et al
.
Comparative study of the effects of a 1-year dietary intervention of a low-carbohydrate diet versus a low-fat diet on weight and glycemic control in type 2 diabetes
.
Diabetes Care
2009
;
32
:
1147
1152
72.
Esposito
K
,
Maiorino
MI
,
Ciotola
M
, et al
.
Effects of a Mediterranean-style diet on the need for antihyperglycemic drug therapy in patients with newly diagnosed type 2 diabetes: a randomized trial
.
Ann Intern Med
2009
;
151
:
306
314
73.
Larsen
RN
,
Mann
NJ
,
Maclean
E
,
Shaw
JE
.
The effect of high-protein, low-carbohydrate diets in the treatment of type 2 diabetes: a 12 month randomised controlled trial
.
Diabetologia
2011
;
54
:
731
740
74.
Krebs
JD
,
Elley
CR
,
Parry-Strong
A
, et al
.
The Diabetes Excess Weight Loss (DEWL) Trial: a randomised controlled trial of high-protein versus high-carbohydrate diets over 2 years in type 2 diabetes
.
Diabetologia
2012
;
55
:
905
914
75.
Guldbrand
H
,
Dizdar
B
,
Bunjaku
B
, et al
.
In type 2 diabetes, randomisation to advice to follow a low-carbohydrate diet transiently improves glycaemic control compared with advice to follow a low-fat diet producing a similar weight loss
.
Diabetologia
2012
;
55
:
2118
2127
76.
Pi-Sunyer
X
,
Blackburn
G
,
Brancati
FL
, et al
Look AHEAD Research Group
.
Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the Look AHEAD trial
.
Diabetes Care
2007
;
30
:
1374
1383
77.
Look AHEAD Research Group
.
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes
.
N Engl J Med
2013
;
369
:
145
154
78.
Li
TY
,
Brennan
AM
,
Wedick
NM
,
Mantzoros
C
,
Rifai
N
,
Hu
FB
.
Regular consumption of nuts is associated with a lower risk of cardiovascular disease in women with type 2 diabetes
.
J Nutr
2009
;
139
:
1333
1338
79.
Faulconbridge
LF
,
TA
,
Rubin
RR
, et al
Look AHEAD Research Group
.
One-year changes in symptoms of depression and weight in overweight/obese individuals with type 2 diabetes in the Look AHEAD study
.
Obesity (Silver Spring)
2012
;
20
:
783
793
80.
Foster
GD
,
KE
,
Sanders
MH
, et al
.;
Sleep AHEAD Research Group of Look AHEAD Research Group. A randomized study on the effect of weight loss on obstructive sleep apnea among obese patients with type 2 diabetes: the Sleep AHEAD study
.
Arch Intern Med
2009
;
169
:
1619
1626
81.
Phelan
S
,
Kanaya
AM
,
Subak
LL
, et al
Look AHEAD Research Group
.
Weight loss prevents urinary incontinence in women with type 2 diabetes: results from the Look AHEAD trial
.
J Urol
2012
;
187
:
939
944
82.
Williamson
DA
,
Rejeski
J
,
Lang
W
,
Van Dorsten
B
,
Fabricatore
AN
,
Toledo
K
;
Look AHEAD Research Group. Impact of a weight management program on health-related quality of life in overweight adults with type 2 diabetes
.
Arch Intern Med
2009
;
169
:
163
171
83.
Estruch
R
,
Ros
E
,
J
, et al
PREDIMED Study Investigators
.
Primary prevention of cardiovascular disease with a Mediterranean diet
.
N Engl J Med
2013
;
368
:
1279
1290
84.
Gregg
EW
,
Chen
H
,
Wagenknecht
LE
, et al
Look AHEAD Research Group
.
Association of an intensive lifestyle intervention with remission of type 2 diabetes
.
JAMA
2012
;
308
:
2489
2496
85.
Franz
MJ
,
Van Wormer
JJ
,
Crain
AL
, et al
.
Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up
.
J Am Diet Assoc
2007
;
107
:
1755
1767
86.
Warshaw
HS
.
Nutrition therapy for adults with type 2 diabetes
. In
American Diabetes Association Guide to Nutrition Therapy for Diabetes.
Franz
MJ
,
Evert
AB
, Eds. Alexandria, VA, American Diabetes Association,
2012
, p.
117
142
87.
Raynor
HA
,
Jeffery
RW
,
Ruggiero
AM
,
Clark
JM
,
Delahanty
LM
,
Look
(Action for Health in Diabetes) Research Group. Weight loss strategies associated with BMI in overweight adults with type 2 diabetes at entry into the Look AHEAD (Action for Health in Diabetes) trial
.
Diabetes Care
2008
;
31
:
1299
1304
88.
Wheeler
ML
,
Dunbar
SA
,
Jaacks
LM
, et al
.
Macronutrients, food groups, and eating patterns in the management of diabetes: a systematic review of the literature
,
2010
.
Diabetes Care
2012
;
35
:
434
445
89.
Delahanty
LM
,
Nathan
DM
,
Lachin
JM
, et al
.;
Diabetes Control and Complications Trial/Epidemiology of Diabetes. Association of diet with glycated hemoglobin during intensive treatment of type 1 diabetes in the Diabetes Control and Complications Trial
.
Am J Clin Nutr
2009
;
89
:
518
524
90.
Vitolins
MZ
,
Anderson
AM
,
Delahanty
L
, et al
Look AHEAD Research Group
.
Action for Health in Diabetes (Look AHEAD) trial: baseline evaluation of selected nutrients and food group intake
.
J Am Diet Assoc
2009
;
109
:
1367
1375
91.
Oza-Frank
R
,
Cheng
YJ
,
Narayan
KM
,
Gregg
EW
.
Trends in nutrient intake among adults with diabetes in the United States: 1988–2004
.
J Am Diet Assoc
2009
;
109
:
1173
1178
92.
Stern
L
,
Iqbal
N
,
P
, et al
.
The effects of low-carbohydrate versus conventional weight loss diets in severely obese adults: one-year follow-up of a randomized trial
.
Ann Intern Med
2004
;
140
:
778
785
93.
Turner-McGrievy
GM
,
Barnard
ND
,
Cohen
J
,
Jenkins
DJ
,
Gloede
L
,
Green
AA
.
Changes in nutrient intake and dietary quality among participants with type 2 diabetes following a low-fat vegan diet or a conventional diabetes diet for 22 weeks
.
J Am Diet Assoc
2008
;
108
:
1636
1645
94.
Schwerin
HS
,
Stanton
JL
,
Smith
JL
,
Riley
AM
Jr
,
Brett
BE
.
Food, eating habits, and health: a further examination of the relationship between food eating patterns and nutritional health
.
Am J Clin Nutr1982
;
35
(
Suppl.
):
1319
1325
95.
Jones-McLean
EM
,
Shatenstein
B
,
Whiting
SJ
.
Dietary patterns research and its applications to nutrition policy for the prevention of chronic disease among diverse North American populations
.
Appl Physiol Nutr Metab
2010
;
35
:
195
198
96.
Heising
ETA
.
The Mediterranean diet and food culture: a symposium
.
Eur J Clin Nutr
1993
;
47
:
1
100
97.
Craig
WJ
,
Mangels
AR
;
American Dietetic Association. Position of the American Dietetic Association: vegetarian diets
.
J Am Diet Assoc
2009
;
109
:
1266
1282
98.
National Heart, Lung, and Blood Institute
.
Your Guide to Lowering Your Cholesterol With TLC [Internet]
. Available from http://www.nhlbi.nih.gov/health/public/heart/chol/chol_tlc.pdf. U.S. Department of Health and Human Services,
2005
(NIH Publication No. 06–5235)
99.
Harsha
DW
,
Lin
PH
,
Obarzanek
E
,
Karanja
NM
,
Moore
TJ
,
Caballero B; DASH Collaborative Research Group. Dietary Approaches to Stop Hypertension: a summary of study results
.
J Am Diet Assoc
1999
;
99
(
Suppl.
):
S35
S39
100.
Elhayany
A
,
Lustman
A
,
Abel
R
,
Attal-Singer
J
,
Vinker
S
.
A low carbohydrate Mediterranean diet improves cardiovascular risk factors and diabetes control among overweight patients with type 2 diabetes mellitus: a 1-year prospective randomized intervention study
.
Diabetes Obes Metab
2010
;
12
:
204
209
101.
Nicholson
AS
,
Sklar
M
,
Barnard
ND
,
Gore
S
,
Sullivan
R
,
Browning
S
.
Toward improved management of NIDDM: a randomized, controlled, pilot intervention using a low fat, vegetarian diet
.
Prev Med
1999
;
29
:
87
91
102.
S
,
Butler
T
,
Yan
R
,
Fraser
GE
.
Type of vegetarian diet, body weight, and prevalence of type 2 diabetes
.
Diabetes Care
2009
;
32
:
791
796
103.
Kahleova
H
,
Matoulek
M
,
Malinska
H
, et al
.
Vegetarian diet improves insulin resistance and oxidative stress markers more than conventional diet in subjects with type 2 diabetes
.
Diabet Med
2011
;
28
:
549
559
103a.
Papakonstantinou
E
,
Triantafillidou
D
,
Panaqiotakos
DB
, et al
.
A high-protein low-fat diet is more effective in improving blood pressure and triglycerides in calorie-restricted obese individuals with newly diagnosed type 2 diabetes
.
Eur J Clin Nutr
2010
;
64
:
595
602
103b.
Kodama
S
,
Saito
K
,
Tanaka
S
, et al
.
Influence of fat and carbohydrate proportions on the metabolic profile in patients with type 2 diabetes: a meta-analysis
.
Diabetes Care
2009
;
32
:
959
965
104.
Sacks
FM
,
Svetkey
LP
,
Vollmer
WM
, et al
.;
DASH-Sodium Collaborative Research Group. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet
.
N Engl J Med
2001
;
344
:
3
10
105.
U.S. Department of Health and Human Services and U.S. Department of Agriculture
. Dietary Guidelines for Americans, 2010 [Internet]. Available from www.health.gov/dietaryguidelines/. Accessed 30 June
2011
106.
Appel
LJ
,
Moore
TJ
,
Obarzanek
E
, et al
DASH Collaborative Research Group
.
A clinical trial of the effects of dietary patterns on blood pressure
.
N Engl J Med
1997
;
336
:
1117
1124
107.
Miyashita
Y
,
Koide
N
,
Ohtsuka
M
, et al
.
Beneficial effect of low carbohydrate in low calorie diets on visceral fat reduction in type 2 diabetic patients with obesity
.
Diabetes Res Clin Pract
2004
;
65
:
235
241
108.
Shai
I
,
Schwarzfuchs
D
,
Henkin
Y
, et al
.;
Dietary Intervention Randomized Controlled Trial (DIRECT) Group. Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet
.
N Engl J Med
2008
;
359
:
229
241
109.
Jönsson
T
,
Granfeldt
Y
,
Ahrén
B
, et al
.
Beneficial effects of a Paleolithic diet on cardiovascular risk factors in type 2 diabetes: a randomized cross-over pilot study
.
Cardiovasc Diabetol
2009
;
8
:
35
110.
Khoo
J
,
C
,
Duncan
R
, et al
.
Comparing effects of a low-energy dietand a high-protein low-fat diet on sexual and endothelial function, urinary tract symptoms, and inflammation in obese diabetic men
.
J Sex Med
2011
;
8
:
2868
2875
111.
Jenkins
DJ
,
Kendall
CW
,
Banach
MS
, et al
.
Nuts as a replacement for carbohydrates in the diabetic diet
.
Diabetes Care
2011
;
34
:
1706
1711
112.
Daly
ME
,
Paisey
R
,
Paisey
R
, et al
.
Short-term effects of severe dietary carbohydrate-restriction advice in type 2 diabetes—a randomized controlled trial
.
Diabet Med
2006
;
23
:
15
20
113.
Dyson
PA
,
Beatty
S
,
Matthews
DR
.
A low-carbohydrate diet is more effective in reducing body weight than healthy eating in both diabetic and non-diabetic subjects
.
Diabet Med
2007
;
24
:
1430
1435
114.
Wolever
TM
,
Gibbs
AL
,
Mehling
C
, et al
.
The Canadian Trial of Carbohydrates in Diabetes (CCD), a 1-y controlled trial of low-glycemic-index dietary carbohydrate in type 2 diabetes: no effect on glycated hemoglobin but reduction in C-reactive protein
.
Am J Clin Nutr
2008
;
87
:
114
125
115.
Kirk
JK
,
Graves
DE
,
Craven
TE
,
Lipkin
EW
,
Austin
M
,
Margolis
KL
.
Restricted-carbohydrate diets in patients with type 2 diabetes: a meta-analysis
.
J Am Diet Assoc
2008
;
108
:
91
100
116.
Iqbal
N
,
Vetter
ML
,
Moore
RH
, et al
.
Effects of a low-intensity intervention that prescribed a low-carbohydrate vs. a low-fat diet in obese, diabetic participants
.
Obesity (Silver Spring)
2010
;
18
:
1733
1738
117.
Jenkins
DJ
,
Kendall
CW
,
McKeown-Eyssen
G
, et al
.
Effect of a low-glycemic index or a high-cereal fiber diet on type 2 diabetes: a randomized trial
.
JAMA
2008
;
300
:
2742
2753
118.
Jenkins
DJ
,
Srichaikul
K
,
Kendall
CW
, et al
.
The relation of low glycaemic index fruit consumption to glycaemic control and risk factors for coronary heart disease in type 2 diabetes
.
Diabetologia
2011
;
54
:
271
279
119.
Jenkins
DJ
,
Kendall
CW
,
Augustin
LS
, et al
.
Effect of legumes as part of a low glycemic index diet on glycemic control and cardiovascular risk factors in type 2 diabetes mellitus: a randomized controlled trial
.
Arch Intern Med
2012
;
172
:
1653
1660
120.
Thomas
D
,
Elliott
EJ
.
Low glycaemic index, or low glycaemic load, diets for diabetes mellitus
.
Cochrane Database Syst Rev
2009
;
1
:CD006296
121.
Fabricatore
AN
,
TA
,
Ebbeling
CB
, et al
.
Targeting dietary fat or glycemic load in the treatment of obesity and type 2 diabetes: a randomized controlled trial
.
Diabetes Res Clin Pract
2011
;
92
:
37
45
122.
Brazeau
AS
,
Mircescu
H
, Desjardins K,et al.
Carbohydrate counting accuracy and blood glucose variability in adults with type 1 diabetes
.
Diabetes Res Clin Pract
2013
;
99
:
19
23
123.
Delahanty
LM
,
Halford
BN
.
The role of diet behaviors in achieving improved glycemic control in intensively treated patients in the Diabetes Control and Complications Trial
.
Diabetes Care
1993
;
16
:
1453
1458
124.
Mann
JI
,
De Leeuw
I
,
Hermansen
K
, et al
.;
Diabetes and Nutrition Study Group (DNSG) of the European Association. Evidence-based nutritional approaches to the treatment and prevention of diabetes mellitus
.
Nutr Metab Cardiovasc Dis
2004
;
14
:
373
394
125.
Dyson
PA
,
Kelly
T
,
Deakin
T
, et al
.;
Diabetes UK Nutrition Working Group. Diabetes UK evidence-based nutrition guidelines for the prevention and management of diabetes
.
Diabet Med
2011
;
28
:
1282
1288
126.
Franz
MJ
.
Diabetes mellitus nutrition therapy: beyond the glycemic index
.
Arch Intern Med
2012
;
172
:
1660
1661
127.
Thomas
DE
,
Elliott
EJ
.
The use of low-glycaemic index diets in diabetes control
.
Br J Nutr
2010
;
104
:
797
802
128.
He
M
,
van Dam
RM
,
Rimm
E
,
Hu
FB
,
Qi L. Whole-grain, cereal fiber, bran, andgerm intake and the risks of all-cause and cardiovascular disease-specific mortality among women with type 2 diabetes mellitus
.
Circulation
2010
;
121
:
2162
2168
129.
Burger
KN
,
Beulens
JW
,
van der Schouw
YT
, et al
.
Dietary fiber, carbohydrate quality and quantity, and mortality risk of individuals with diabetes mellitus
.
PLoS ONE
2012
;
7
:e43127
130.
Post
RE
,
Mainous
AG
3rd
,
King
DE
,
Simpson
KN
.
Dietary fiber for the treatment of type 2 diabetes mellitus: a meta-analysis
.
J Am Board Fam Med
2012
;
25
:
16
23
131.
Barnard
ND
,
Cohen
J
,
Jenkins
DJ
, et al
.
A low-fat vegan diet and a conventional diabetes diet in the treatment of type 2 diabetes: a randomized, controlled, 74-wk clinical trial
.
Am J Clin Nutr
2009
;
89
:
1588S
1596S
132.
De Natale
C
,
Annuzzi
G
,
Bozzetto
L
, et al
.
Effects of a plant-based high-carbohydrate/high-fiber diet versus high-monounsaturated fat/low-carbohydrate diet on postprandial lipids in type 2 diabetic patients
.
Diabetes Care
2009
;
32
:
2168
2173
133.
Wolfram
T
,
Ismail-Beigi
F
.
Efficacy of high-fiber diets in the management of type 2 diabetes mellitus
.
Endocr Pract
2011
;
17
:
132
142
134.
Slavin
JL
.
Position of the American Dietetic Association: health implications of dietary fiber
.
J Am Diet Assoc
2008
;
108
:
1716
1731
135.
Bonsu
NK
,
Johnson
CS
,
McLeod
KM
.
Can dietary fructans lower serum glucose?
J Diabetes
2011
;
3
:
58
66
136.
Sievenpiper
JL
,
Carleton
AJ
,
Chatha
S
, et al
.
Heterogeneous effects of fructose on blood lipids in individuals with type 2 diabetes: systematic review and meta-analysis of experimental trials in humans
.
Diabetes Care
2009
;
32
:
1930
1937
137.
Livesey
G
,
Taylor
R
.
Fructose consumption and consequences for glycation, plasma triacylglycerol, and body weight: meta-analyses and meta-regression models of intervention studies
.
AmJ Clin Nutr
2008
;
88
:
1419
1437
138.
Cozma
AI
,
Sievenpiper
JL
,
de Souza
RJ
, et al
.
Effect of fructose on glycemic control in diabetes: a systematic review and meta-analysis of controlled feeding trials
.
Diabetes Care
2012
;
35
:
1611
1620
139.
Husband
AC
,
Crawford
S
,
McCoy
LA
,
Pacaud
D
.
The effectiveness of glucose, sucrose, and fructose in treating hypoglycemia in children with type 1 diabetes
.
Pediatr Diabetes
2010
;
11
:
154
158
140.
Schulze
MB
,
Manson
JE
,
Ludwig
DS
, et al
.
Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women
.
JAMA
2004
;
292
:
927
934
141.
Malik
VS
,
Popkin
BM
,
Bray
GA
,
Després
JP
,
Willett
WC
,
Hu
FB
.
Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis
.
Diabetes Care
2010
;
33
:
2477
2483
142.
Stanhope
KL
,
Schwarz
JM
,
Keim
NL
, et al
.
Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans
.
J Clin Invest
2009
;
119
:
1322
1334
143.
Dhingra
R
,
Sullivan
L
,
Jacques
PF
, et al
.
Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community
.
Circulation
2007
;
1
16
:
480
488
144.
Nettleton
JA
,
Lutsey
PL
,
Wang
Y
,
Lima
JA
,
Michos
ED
,
Jacobs
DR
Jr
.
Diet soda intake and risk of incident metabolic syndrome and type 2 diabetes in the Multi-Ethnic Study of Atherosclerosis (MESA)
.
Diabetes Care
2009
;
32
:
688
694
145.
U.S. Department of Agriculture
. Nutritive and Nonnutritive Sweetener Resources [Internet],
2013
. Available from http://fnic.nal.usda.gov/food-composition/nutritive-and-nonnutritive-sweetener-resources. National Agricultural Library, Food and Nutrition Information Center. Accessed 13 August 2013
146.
Gardner
C
,
Wylie-Rosett
J
,
Gidding
SS
, et al
.;
American Heart Association Nutrition Committee of the Council on Nutrition, Physical Activity and Metabolism, Council on Arteriosclerosis, Thrombosis and Vascular Biology, Council on Cardiovascular Disease in the Young; American Diabetes Association. Nonnutritive sweeteners: current use and health perspectives: a scientific statement from the American Heart Association and the American Diabetes Association
.
Diabetes Care
2012
;
35
:
1798
1808
147.
Wiebe
N
,
R
,
Field
C
,
Marks
S
,
Jacobs
R
,
Tonelli
M
.
A systematic review on the effect of sweeteners on glycemic response and clinically relevant outcomes
.
BMC Med
2011
;
9
:
123
148.
Gannon
MC
,
Nuttall
FQ
,
Saeed
A
,
Jordan
K
,
Hoover
H
.
An increase in dietary protein improves the blood glucose response in persons with type 2 diabetes
.
Am J Clin Nutr
2003
;
78
:
734
741
149.
Wycherley
TP
,
Noakes
M
,
Clifton
PM
,
Cleanthous
X
,
Keogh
JB
,
Brinkworth
GD
.
A high-protein diet with resistance exercise training improves weight loss and body composition in overweight and obese patients with type 2 diabetes
.
Diabetes Care
2010
;
33
:
969
976
150.
Parker
B
,
Noakes
M
,
Luscombe
N
,
Clifton
P
.
Effect of a high-protein, high-monounsaturated fat weight loss diet on glycemic control and lipid levels in type 2 diabetes
.
Diabetes Care
2002
;
25
:
425
430
151.
Brinkworth
GD
,
Noakes
M
,
Parker
B
,
Foster
P
,
Clifton
PM
.
Long-term effects of advice to consume a high-protein, low-fat diet, rather than a conventional weight-loss diet, in obese adults with type 2 diabetes: one-year follow-up of a randomised trial
.
Diabetologia
2004
;
47
:
1677
1686
152.
Pijls
LT
,
de Vries
H
,
van Eijk
JT
,
Donker
AJ
.
Protein restriction, glomerular filtration rate and albuminuria in patients with type 2 diabetes mellitus: a randomized trial
.
Eur J Clin Nutr
2002
;
56
:
1200
1207
153.
Meloni
C
,
Tatangelo
P
,
Cipriani
S
, et al
.
Adequate protein dietary restriction in diabetic and nondiabetic patients with chronic renal failure
.
J Ren Nutr
2004
;
14
:
208
213
154.
Hansen
HP
,
Tauber-Lassen
E
,
Jensen
BR
,
Parving
HH
.
Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy
.
Kidney Int
2002
;
62
:
220
228
155.
Dussol
B
,
Iovanna
C
,
Raccah
D
, et al
.
A randomized trial of low-protein diet in type 1 and in type 2 diabetes mellitus patients with incipient and overt nephropathy
.
J Ren Nutr
2005
;
15
:
398
406
156.
Gross
JL
,
Zelmanovitz
T
,
Moulin
CC
, et al
.
Effect of a chicken-based diet on renal function and lipid profile in patients with type 2 diabetes: a randomized crossover trial
.
Diabetes Care
2002
;
25
:
645
651
157.
Pan
Y
,
Guo
LL
,
Jin
HM
.
Low-protein diet for diabetic nephropathy: a meta-analysis of randomized controlled trials
.
Am J Clin Nutr
2008
;
88
:
660
666
158.
Robertson
L
,
Waugh
N
,
Robertson
A
.
Protein restriction for diabetic renal disease
.
Cochrane Database Syst Rev
2007
;
4
:CD002181
159.
Teixeira
SR
,
Tappenden
KA
,
Carson
L
, et al
.
Isolated soy protein consumption reduces urinary albumin excretion and improves the serum lipid profile in men with type 2 diabetes mellitus and nephropathy
.
J Nutr
2004
;
134
:
1874
1880
160.
L
,
Atabak
S
,
A
.
Soy protein intake, cardiorenal indices, and C-reactive protein in type 2 diabetes with nephropathy: a longitudinal randomized clinical trial
.
Diabetes Care
2008
;
31
:
648
654
161.
Gannon
MC
,
Nuttall
JA
,
Damberg
G
,
Gupta
V
,
Nuttall
FQ
.
Effect of protein ingestion on the glucose appearance rate in people with type 2 diabetes
.
J Clin Endocrinol Metab
2001
;
86
:
1040
1047
162.
Papakonstantinou
E
,
Triantafillidou
D
,
Panagiotakos
DB
,
Iraklianou
S
,
Berdanier
CD
,
Zampelas
A
.
A high protein low fat meal does not influence glucose and insulin responses in obese individuals with or without type 2 diabetes
.
J Hum Nutr Diet
2010
;
23
:
183
189
163.
Nordt
TK
,
Besenthal
I
,
Eggstein
M
,
Jakober
B
.
Influence of breakfasts with different nutrient contents on glucose, C peptide, insulin, glucagon, triglycerides, and GIP in non-insulin-dependent diabetics
.
Am J Clin Nutr
1991
;
53
:
155
160
164.
Nuttall
FQ
,
,
Gannon
MC
,
Billington
C
,
Krezowski
P
.
Effect of protein ingestion on the glucose and insulin response to a standardized oral glucose load
.
Diabetes Care
1984
;
7
:
465
470
165.
Gray
RO
,
Butler
PC
,
Beers
TR
,
Kryshak
EJ
,
Rizza
RA
.
Comparison of the ability of bread versus bread plus meat to treat and prevent subsequent hypoglycemia in patients with insulin-dependent diabetes mellitus
.
J Clin Endocrinol Metab
1996
;
81
:
1508
1511
166.
Peters
AL
,
Davidson
MB
.
Protein and fat effects on glucose responses and insulin requirements in subjects with insulin-dependent diabetes mellitus
.
Am J Clin Nutr
1993
;
58
:
555
560
167.
Institute of Medicine
.
Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids
.
Washington, DC
,
,
2002
168.
Ros
E
.
Dietary cis-monounsaturated fatty acids and metabolic control in type 2 diabetes
.
Am J Clin Nutr
2003
;
78
(
Suppl.
):
617S
625S
169.
Schwingshackl
L
,
Strasser
B
,
Hoffmann
G
.
Effects of monounsaturated fatty acids on glycaemic control in patients with abnormal glucose metabolism: a systematic review and meta-analysis
.
Ann Nutr Metab
2011
;
58
:
290
296
170.
Itsiopoulos
C
,
Brazionis
L
,
Kaimakamis
M
, et al
.
Can the Mediterranean diet lower HbA1c in type 2 diabetes? Results from a randomized cross-over study
.
Nutr Metab Cardiovasc Dis
2011
;
21
:
740
747
171.
Tanasescu
M
,
Cho
E
,
Manson
JE
,
Hu
FB
.
Dietary fat and cholesterol and the risk of cardiovascular disease among women with type 2 diabetes
.
Am J Clin Nutr
2004
;
79
:
999
1005
172.
Brunerova
L
,
Smejkalova
V
,
Potockova
J
,
Andel
M
.
A comparison of the influence of a high-fat diet enriched in monounsaturated fatty acids and conventional diet on weight loss and metabolic parameters in obese non-diabetic and type 2 diabetic patients
.
Diabet Med
2007
;
24
:
533
540
173.
Academy of Nutrition and Dietetics Evidence Analysis Library
. Available from http://andevidencelibrary.com/template.cfm?template=guide_summary&key=2984#supportevidence [Internet],
2011
174.
Harris
WS
,
Mozaffarian
D
,
Rimm
E
, et al
.
Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention
.
Circulation
2009
;
119
:
902
907
175.
Crochemore
IC
,
Souza
AF
,
de Souza
AC
,
EL
.
ω-3 Polyunsaturated fatty acid supplementation does not influence body composition, insulin resistance, and lipemia in women with type 2 diabetes and obesity
.
Nutr Clin Pract
2012
;
27
:
553
560
176.
Bot
M
,
Pouwer
F
,
Assies
J
,
Jansen
EH
,
Beekman
AT
,
de Jonge
P
.
Supplementation with eicosapentaenoic omega-3 fatty acid does not influence serum brain-derived neurotrophic factor in diabetes mellitus patients with major depression: a randomized controlled pilot study
.
Neuropsychobiology
2011
;
63
:
219
223
177.
Mas
E
,
Woodman
RJ
,
Burke
V
, et al
.
The omega-3 fatty acids EPA and DHA decrease plasma F(2)-isoprostanes: results from two placebo-controlled interventions
.
2010
;
44
:
983
990
178.
Stirban
A
,
Nandrean
S
,
Götting
C
, et al
.
Effects of n-3 fatty acids on macro- and microvascular function in subjects with type 2 diabetes mellitus
.
Am J Clin Nutr
2010
;
91
:
808
813
179.
Wong
CY
,
Yiu
KH
,
Li
SW
, et al
.
Fish-oil supplement has neutral effects on vascular and metabolic function but improves renal function in patients with type 2 diabetes mellitus
.
Diabet Med
2010
;
27
:
54
60
180.
A
,
Saedisomeolia
A
,
Djalali
M
,
Djazayery
A
,
Pooya
S
,
Sojoudi
F
.
Efficacy of omega-3 fatty acid supplementation on serum levels of tumour necrosis factor-alpha, C-reactive protein and interleukin-2 in type 2 diabetes mellitus patients
.
Singapore Med J
2012
;
53
:
615
619
181.
Taylor
CG
,
Noto
,
Stringer
DM
,
Froese
S
,
Malcolmson
L
.
Dietary milled flaxseed and flaxseed oil improve n-3 fatty acid status and do not affect glycemic control in individuals with well-controlled type 2 diabetes
.
J Am Coll Nutr
2010
;
29
:
72
80
182.
Holman
RR
,
Paul
S
,
Farmer
A
,
Tucker
L
,
Stratton
IM
,
Neil
HA
;
Atorvastatin in Factorial with Omega-3 EE90 Risk Reduction in Diabetes Study Group. Atorvastatin in Factorial with Omega-3 EE90 Risk Reduction in Diabetes (AFORRD): a randomised controlled trial
.
Diabetologia
2009
;
52
:
50
59
183.
Kromhout
D
,
Geleijnse
JM
,
de Goede
J
, et al
.
n-3 Fatty acids, ventricular arrhythmia-related events, and fatal myocardial infarction in postmyocardial infarction patients with diabetes
.
Diabetes Care
2011
;
34
:
2515
2520
184.
Bosch
J
,
Gerstein
HC
,
Dagenais
GR
, et al
.;
ORIGIN Trial Investigators. n-3 Fatty acids and cardiovascular outcomes in patients with dysglycemia
.
N Engl J Med
2012
;
367
:
309
318
185.
Karlström
BE
,
Järvi
AE
,
Byberg
L
,
Berglund
LG
,
Vessby
BO
.
Fatty fish in the diet of patients with type 2 diabetes: comparison of the metabolic effects of foods rich in n-3 and n-6 fatty acids
.
Am J Clin Nutr
2011
;
94
:
26
33
186.
Rivellese
AA
,
Giacco
R
,
Annuzzi
G
, et al
.
Effects of monounsaturated vs. saturated fat on postprandial lipemia and adipose tissue lipases in type 2 diabetes
.
Clin Nutr
2008
;
27
:
133
141
187.
Academy of Nutrition and Dietetics Evidence Analysis Library
. Disorders of Lipid Metabolism (DLM) and Plant Stanols and Sterols [Internet],
2004
. Available from http://andevidencelibrary.com/template.cfm?key=2986&auth=1. Accessed 8 April 2013
188.
Hallikainen
M
,
Lyyra-Laitinen
T
,
Laitinen
T
,
Moilanen
L
,
Miettinen
TA
,
Gylling
H
.
Effects of plant stanol esters on serum cholesterol concentrations, relative markers of cholesterol metabolism and endothelial function in type 1 diabetes
.
Atherosclerosis
2008
;
199
:
432
439
189.
Hallikainen
M
,
Kurl
S
,
Laakso
M
,
Miettinen
TA
,
Gylling
H
.
Plant stanolesters lower LDL cholesterol level in statin-treated subjects with type 1 diabetes by interfering the absorption and synthesis of cholesterol
.
Atherosclerosis
2011
;
217
:
473
478
190.
Lee
YM
,
Haastert
B
,
Scherbaum
W
,
Hauner
H
.
A phytosterol-enriched spread improves the lipid profile of subjects with type 2 diabetes mellitus—a randomized controlled trial under free-living conditions
.
Eur J Nutr
2003
;
42
:
111
117
191.
Lau
VW
,
Journoud
M
,
Jones
PJ
.
Plantsterols are efficacious in lowering plasma LDL and non-HDL cholesterol in hypercholesterolemic type 2 diabetic and nondiabetic persons
.
Am J Clin Nutr
2005
;
81
:
1351
1358
192.
Yoshida
M
,
Vanstone
CA
,
Parsons
WD
,
Zawistowski
J
,
Jones
PJ
.
Effect of plant sterols and glucomannan on lipids in individuals with and without type II diabetes
.
Eur J Clin Nutr
2006
;
60
:
529
537
193.
Sesso
HD
,
Christen
WG
,
Bubes
V
, et al
.
Multivitamins in the prevention of cardiovascular disease in men: the Physicians’ Health Study II randomized controlled trial
.
JAMA
2012
;
308
:
1751
1760
194.
Macpherson
H
,
Pipingas
A
,
Pase
MP
.
Multivitamin-multimineral supplementation and mortality: a meta-analysis of randomized controlled trials
.
Am J Clin Nutr
2013
;
97
:
437
444
195.
,
Morley
JE
.
Micronutrient status in diabetes mellitus
.
Am J Clin Nutr
1987
;
45
:
877
895
196.
Franz
MJ
,
Bantle
JP
,
Beebe
CA
, et al
.
Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications
.
Diabetes Care
2002
;
25
:
148
198
197.
Stampfer
MJ
,
Hennekens
CH
,
Manson
JE
,
Colditz
GA
,
Rosner
B
,
Willett
WC
.
Vitamin E consumption and the risk of coronary disease in women
.
N Engl J Med
1993
;
328
:
1444
1449
198.
Yochum
LA
,
Folsom
AR
,
Kushi
LH
.
Intake of antioxidant vitamins and risk of death from stroke in postmenopausal women
.
Am J Clin Nutr
2000
;
72
:
476
483
199.
Hasanain
B
,
.
Antioxidant vitamins and their influence in diabetes mellitus
.
Curr Diab Rep
2002
;
2
:
448
456
200.
Lonn
E
,
Yusuf
S
,
Hoogwerf
B
, et al
HOPE Study; MICRO-HOPE Study
.
Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy
.
Diabetes Care
2002
;
25
:
1919
1927
201.
Miller
ER
3rd
,
Pastor-Barriuso
R
,
Dalal
D
,
Riemersma
RA
,
Appel
L J
,
Guallar
E
.
Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality
.
Ann Intern Med
2005
;
142
:
37
46
202.
Belch
J
,
MacCuish
A
,
Campbell
I
, et al
.
The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease
.
BMJ
2008
;
337
:a1840
203.
Kataja-Tuomola
MK
,
Kontto
JP
,
Männistö
S
,
Albanes
D
,
Virtamo
JR
.
Effect of alpha-tocopherol and beta-carotene supplementation on macrovascular complications and total mortality from diabetes: results of the ATBC Study
.
Ann Med
2010
;
42
:
178
186
204.
Balk
EM
,
Tatsioni
A
,
Lichtenstein
AH
,
Lau
J
,
Pittas
AG
.
Effect of chromium supplementation on glucose metabolism and lipids: a systematic review of randomized controlled trials
.
Diabetes Care
2007
;
30
:
2154
2163
205.
Rodríguez-Morán
M
,
Guerrero-Romero
F
.
Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial
.
Diabetes Care
2003
;
26
:
1147
1152
206.
de Valk
HW
,
Verkaaik
R
,
van Rijn
HJ
,
Geerdink
RA
,
Struyvenberg
A
.
Oral magnesium supplementation in insulin-requiring type 2 diabetic patients
.
Diabet Med
1998
;
15
:
503
507
207.
Jorde
R
,
Figenschau
Y
.
Supplementation with cholecalciferol does not improve glycaemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levels
.
Eur J Nutr
2009
;
48
:
349
354
208.
Patel
P
,
Poretsky
L
,
Liao
E
.
Lack of effect of subtherapeutic vitamin D treatment on glycemic and lipid parameters in type 2 diabetes: a pilot prospective randomized trial
.
J Diabetes
2010
;
2
:
36
40
209.
Parekh
D
,
Sarathi
V
,
Shivane
VK
,
Bandgar
TR
,
Menon
PS
,
Shah
NS
.
Pilot study to evaluate the effect of short-term improvement in vitamin D status on glucose tolerance in patients with type 2 diabetes mellitus
.
Endocr Pract
2010
;
16
:
600
608
210.
Nikooyeh
B
,
Neyestani
TR
,
Farvid
M
, et al
.
Daily consumption of vitamin D- or vitamin D + calcium-fortified yogurt drink improved glycemic control in patients with type 2 diabetes: a randomized clinical trial
.
Am J Clin Nutr
2011
;
93
:
764
771
211.
Soric
MM
,
Renner
ET
,
Smith
SR
.
Effect of daily vitamin D supplementation on HbA1c in patients with uncontrolled type 2 diabetes mellitus: a pilot study
.
J Diabetes
2012
;
4
:
104
105
212.
Leach
MJ
,
Kumar
S
.
Cinnamon for diabetes mellitus
.
Cochrane Database Syst Rev
2012
;
9
:CD007170
213.
Yeh
GY
,
Eisenberg
DM
,
Kaptchuk
TJ
,
Phillips
RS
.
Systematic review of herbs and dietary supplements for glycemic control in diabetes
.
Diabetes Care
2003
;
26
:
1277
1294
214.
Tariq
SH
.
Herbal therapies
.
Clin Geriatr Med
2004
;
20
:
237
257
215.
Mackenzie
T
,
Brooks
B
,
O’Connor
G
.
Beverage intake, diabetes, and glucose control of adults in America
.
Ann Epidemiol
2006
;
16
:
688
691
216.
Kerr
D
,
Cheyne
E
,
Thomas
P
,
Sherwin
R
.
Influence of acute alcohol ingestion on the hormonal responses to modest hypoglycaemia in patients with type 1 diabetes
.
Diabet Med
2007
;
24
:
312
316
217.
Shai
I
,
Wainstein
J
,
Harman-Boehm
I
, et al
.
Glycemic effects of moderate alcohol intake among patients with type 2 diabetes: a multicenter, randomized, clinical intervention trial
.
Diabetes Care
2007
;
30
:
3011
3016
218.
Ahmed
AT
,
Karter
AJ
,
Warton
EM
,
Doan
JU
,
Weisner
CM
.
The relationship between alcohol consumption and glycemic control among patients with diabetes: the Kaiser Permanente Northern California Diabetes Registry
.
J Gen Intern Med
2008
;
23
:
275
282
219.
Bantle
AE
,
Thomas
W
,
Bantle
JP
.
Metabolic effects of alcohol in the form of wine in persons with type 2 diabetes mellitus
.
Metabolism
2008
;
57
:
241
245
220.
Tanasescu
M
,
Hu
FB
,
Willett
WC
,
Stampfer
MJ
,
Rimm
EB
.
Alcohol consumption and risk of coronary heart disease among men with type 2 diabetes mellitus
.
J Am Coll Cardiol
2001
;
38
:
1836
1842
221.
Howard
AA
,
Arnsten
JH
,
Gourevitch
MN
.
Effect of alcohol consumption on diabetes mellitus: a systematic review
.
Ann Intern Med
2004
;
140
:
211
219
222.
Beulens
JW
,
Algra
A
,
Soedamah-Muthu
SS
,
Visseren
FL
,
Grobbee
DE
,
van der Graaf
Y
;
SMART Study Group. Alcohol consumption and risk of recurrent cardiovascular events and mortality in patients with clinically manifest vascular disease and diabetes mellitus: the Second Manifestations of ARTerial (SMART) disease study
.
Atherosclerosis
2010
;
212
:
281
286
223.
Nakamura
Y
,
Ueshima
H
,
A
, et al
NIPPON DATA80 Research Group
.
Alcohol intake and 19-year mortality in diabetic men: NIPPON DATA80
.
Alcohol
2009
;
43
:
635
641
224.
Koppes
LL
,
Dekker
JM
,
Hendriks
HF
,
Bouter
LM
,
Heine
RJ
.
Meta-analysis of the relationship between alcohol consumption and coronary heart disease and mortality in type 2 diabetic patients
.
Diabetologia
2006
;
49
:
648
652
225.
Richardson
T
,
Weiss
M
,
Thomas
P
,
Kerr
D
.
Day after the night before: influence of evening alcohol on risk of hypoglycemia in patients with type 1 diabetes
.
Diabetes Care
2005
;
28
:
1801
1802
226.
Lange
J
,
Arends
J
,
Willms
B
.
Alcohol-induced hypoglycemia in type I diabetic patients
.
Med Klin (Munich)
1991
;
86
:
551
554
[in German]
227.
Burge
MR
,
Zeise
TM
,
Sobhy
TA
,
Rassam
AG
,
DS
.
Low-dose ethanol predisposes elderly fasted patients with type 2 diabetes to sulfonylurea-induced low blood glucose
.
Diabetes Care
1999
;
22
:
2037
2043
228.
Suckling
RJ
,
He
FJ
,
Macgregor
GA
.
Altered dietary salt intake for preventing and treating diabetic kidney disease
.
Cochrane Database Syst Rev
2010
;
12
:CD006763
229.
Bray
GA
,
Vollmer
WM
,
Sacks
FM
,
Obarzanek
E
,
Svetkey
LP
,
Appel
LJ
;
DASH Collaborative Research Group. A further subgroup analysis of the effects of the DASH diet and three dietary sodium levels on blood pressure: results of the DASH-Sodium Trial
.
Am J Cardiol
2004
;
94
:
222
227
230.
Thomas
MC
,
Moran
J
,
Forsblom
C
, et al
FinnDiane Study Group
.
The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes
.
Diabetes Care
2011
;
34
:
861
866
231.
Ekinci
EI
,
Clarke
S
,
Thomas
MC
, et al
.
Dietary salt intake and mortality in patients with type 2 diabetes
.
Diabetes Care
2011
;
34
:
703
709
232.
Institute of Medicine
.
Sodium Intake in Populations: Assessment of Evidence
.
Washington, DC
,
National Academy of Sciences
,
2013
233.
Maillot
M
,
Drewnowski
A
.
A conflict between nutritionally adequate diets and meeting the 2010 dietary guidelines for sodium
.
Am J Prev Med
2012
;
42
:
174
179
234.
Centers for Disease Control and Prevention
.
CDC grand rounds: dietary sodium reduction - time for choice
.
MMWR Morb Mortal Wkly Rep
2012
;
61
:
89
91
235.
Appel
LJ
,
Frohlich
ED
,
Hall
JE
, et al
.
The importance of population-wide sodium reduction as a means to prevent cardiovascular disease and stroke: a call to action from the American Heart Association
.
Circulation
2011
;
123
:
1138
1143
236.
World Health Organization
.
Guideline: Sodium intake for adults and children, 2012
.
Geneva
,
World Health Organization
. Available from http://www.who.int/nutrition/publications/guidelines/sodium_intake_printversion.pdf. Accessed 22 September
2013
237.
Institute of Medicine
.
Strategies to Reduce Sodium Intake in the United States
.
Washington, DC
,
,
2010
238.
Spahn
JM
,
Reeves
RS
,
Keim
KS
, et al
.
State of the evidence regarding behavior change theories and strategies in nutrition counseling to facilitate health and food behavior change
.
J Am Diet Assoc
2010
;
110
:
879
891
239.
Cryer
PE
,
Fisher
JN
,
Shamoon
H
.
Hypoglycemia. Diabetes Care
1994
;
17
:
734
755
240.
Wirfält
E
,
Drake
I
,
Wallstrom
P
.
What do review papers conclude about food and dietary patterns?
Food Nutr Res.
4
March
2013
[Epub ahead of print]
241.
Kattelmann
KK
,
Conti
K
,
Ren
C
.
The medicine wheel nutrition intervention: a diabetes education study with the Cheyenne River Sioux Tribe
.
J Am Diet Assoc
2009
;
109
:
1532
1539
242.
Mian
SI
,
Brauer
PM
.
Dietary education tools for South Asians with diabetes
.
Can J Diet Pract Res
2009
;
70
:
28
35
243.
Schillinger
D
,
Grumbach
K
,
Piette
J
, et al
.
Association of health literacy with diabetes outcomes
.
JAMA
2002
;
288
:
475
482
244.
Cavanaugh
K
,
Huizinga
MM
,
Wallston
KA
, et al
.
Association of numeracy and diabetes control
.
Ann Intern Med
2008
;
148
:
737
746
245.
Pan
L
,
Sherry
B
,
Njai
R
,
Blanck
HM
.
Food insecurity is associated with obesity among US adults in 12 states
.
J Acad Nutr Diet
2012
;
1
12
:
1403
1409
246.
Grimm
KA
,
Foltz
JL
,
Blanck
HM
,
Scanlon
KS
.
Household income disparities in fruit and vegetable consumption by state and territory: results of the 2009 Behavioral Risk Factor Surveillance System
.
J Acad Nutr Diet
2012
;
112
:
2014
2021
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.